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The purpose of this study was to determine how different scanning techniques on 4DCT 
images impacted the perceived target volume, and how this in turn affected the dose 
calculation and dose distribution to the target volume. Acquired 4DCT datasets were 
reconstructed to form Maximum Intensity Projections (MIP), Average Intensity 
Projections (AIP) and free breathing datasets. Comparisons of the resultant CT number, 
mass density, point dose values, and dose distribution were made for the different 
datasets. These comparisons showed how different scanning techniques used to 
manipulate the 4DCT dataset affect treatment planning and dose calculation for 
radiotherapy for a moving tumour volume within the lungs. 
 
While the CT numbers for the AIP, MIP and the free breathing datasets were different, 
the resultant density values for the moving target volume showed similar results for the 
MIP and free breathing images. For the MIP dataset, the target volume density ranged 
from 1.03 g/cm
3
 to 1.04 g/cm
3
. For the Free breathing dataset, the volume density 




. The AIP dataset showed lower target volume 
density, ranging from 0.50 g/cm
3




Dose to a point was both measured and calculated for comparison as well. The 
calculated point dose on the different image types was calculated using the Pinnacle
3
 
treatment planning system, while an ionization chamber was used to measure dose to a 
point in the phantom. Results showed lower calculated dose to a point for all the image 
types, in comparison to measured point dose values. However, a more clinically 
relevant assessment would be to compare the dose distribution to the target volume. 
 
Comparisons of the dose distribution for the different image types (the AIP, MIP and 
free breathing) compared to the dose distribution averaged across the 8 phases of the 
4DCT dataset was made. Comparisons were also made with increasing magnitude of 
motion to identify if the results were the same as the magnitude of motion increased. As 
motion increased, it was found that while MIP images were acceptable for dose 




Results obtained here are based on simulated motions on a simplified phantom. 
Although simplified geometries and motions were used in this study, the results provide 
some guidance when applying AIP or MIP related 4DCT treatment planning procedure 
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Cancer is the irregular growth of abnormal cells that divide in an uncontrolled state. 
Cancers can occur in various parts of the body and are able to migrate from the primary 
location to other parts of the body through blood or the lymphatic systems. According to 
the Australian Institute of Health and Welfare [1] in 2017, an estimated 134,174 people 
will be diagnosed with cancer and that 47,753 people will die from it. The Australian 
Burden of Disease study finds that 19% of the total disease burden in Australia is due to 
cancer alone  [2]. In Australia, aside from non-melanoma skin cancer, the most common 
cancers are Prostate, Breast, Colorectal (bowel), Melanoma and Lung cancer [2]. 
 
Interestingly, younger people tend to have different cancers from that of older people. 
According to the Australian cancer database, the more commonly diagnosed cancer that 
afflicts people under the age of 24 are Leukaemia, Lymphoma and Brain cancer. People 
who are between ages 25 to 49 tend to be afflicted by Breast cancer, Melanoma, and 
Colorectal cancer. People who are 65 and over tend to be afflicted by Colorectal, 
Prostate, and Lung cancers [1].  
 
Treatments for cancers are typically through radiation therapy, chemotherapy and 
surgery, used in an optimal combination specific to each patient. Chemotherapy is 
typically used to treat cancers that have spread throughout the body. Strong drugs are 
introduced into the body that are targeted at rapidly dividing cells, which is perhaps the 
main characteristics of cancer cell. This treatment is typically done intravenously where 
medication is slowly introduced into the body through a catheter through a large vein. 
 
1.2 Radiation Therapy 
 
Radiation Therapy, also called radiotherapy, refers to treatment of cancer by irradiating 




both primary and advanced cancers. High doses of radiation are delivered to the tumour 
volume, where upon dose deposition, the ionizing radiation will cause damage to the 
DNA of the cancerous cells [3]. If the cells are damaged enough beyond repair, the 
cancerous cells can then be broken down and removed from the body. Today, 
radiotherapy can be delivered by many means, but more generally, it can be categorized 
into external radiotherapy as well as internal radiotherapy. Internal radiotherapy refers 
to delivering radiation from within the body through a radiation source implanted into 
or near the tumour volume. External beam radiotherapy refers to a means of delivering 
radiation dosage from an external source outside of the body to irradiate the cancerous 
cells. A common delivery of external beam radiotherapy is through a medical linear 
accelerator (commonly known as the LINAC). Radiation beams from linear accelerators 
are usually modulated and shaped as they are delivered to the patient.  
 
Radiotherapy treatments require careful treatment planning before dose delivery. 
Firstly, patients with the tumours are imaged with medical imaging techniques like a CT 
scan. Based on the CT images, treatment plans are created where the tumour and vital 
organs can be delineated and the dose to the various structures can be calculated. This 
involves using specific treatment planning systems on computers to simulate and 
calculate the appropriate amount of dose to the tumour within the patient, to assess the 
viability of the treatment plan. As such, the accuracy of the acquired image is of 
importance in the treatment planning process. 
  
Tumour motion is a challenge that needs to be managed during radiotherapy. Motion 
like respiratory motion can cause blurring artifacts in the images [4]. The motion can be 
large and unpredictable which can lead to inaccurate target delineation [5]. Improper 
motion management can lead to organs at risk being irradiated, or the tumour volume 
not being fully irradiated.  
1.3 4 Dimensional Computed Tomography 
 
Four-Dimensional Computed Tomography(4DCT) used in conjunction with Stereotactic 
Body Radiation Therapy (SBRT) is an excellent means to treat patients with tumours in 
regions of greater motion. SBRT can be defined as a form of external beam 




localized target site [6]. 4DCT images consist of multiple CT slice images taken 
throughout a single respiration cycle of the patient, from end-inspiration to end-
expiration. The unique aspect of this compared to conventional CT scanning is that 
4DCT incorporates both spatial and temporal information of the tumour motion. This 
imaging technique of 4DCT enables capturing of tumour motion more precisely and 
accurately, such that highly conformal radiation therapy in the form of SBRT can be 
delivered to patients. Through 4DCT images, the tumour motion is observed in relation 
to the respiratory motion of the patient. Additionally, it is also possible to observe how 
surrounding healthy tissue affects the motion of the tumour with 4DCT images. As 
such, 4DCT imaging is typically used in treatment for cancers located in or near to the 
heart, liver, breast, and especially in the lungs. 
 
Precise treatment planning is essential such that sufficient radiation is delivered to the 
target volume, while simultaneously avoiding healthy normal organs at risk (OARs). 
The choice of image used for target delineation and dose calculation during treatment 
planning is very important as different image reconstruction methods will produce 
varying outcomes. Outlining the various volumes on every single image in the 4DCT 
image set will be very time consuming. Instead, various image types can be constructed, 
to reduce the work load of the radiation oncologist. These different image types will be 
discussed in the later sections. It would thus be interesting to study how the different 
methods of image reconstruction affects the CT numbers, target delineation and the 
dose calculation as well during treatment planning to find the most optimal image to use 




Due to respiratory motion, treatment planning is especially important to ensure that the 
motion of the tumour volume is accurately captured. Using 4DCT imaging techniques, 
the motion of the tumour in a single respiration cycle can be observed from start 
inspiration to end exhalation.  Based on the 4DCT dataset, new image types like 
Maximum Intensity Projection (MIP), and Average Intensity Projection (AIP) images, 
can be formed to be used for target delineation and dose calculation. Treatment planning 




oncologist during the treatment planning process, compared to planning on all phases of 
the 4DCT dataset. 
 
There are 3 main aims in this thesis, which will be discussed in various chapters; 
 
1) What impact does the 4DCT dataset representation (i.e.: MIP, AIP, or a single 
4DCT phase) have on CT number? 
The initial aim is to study how different reconstructed images based on the 4DCT 
dataset, like the MIP, AIP, or a specific 4DCT phase, affect the resultant CT number of 
the image. This is important because dose calculation is dependent on density as derived 
from CT number. More importantly, the aim is to determine if each of the reconstructed 
images accurately represents the physical density of a moving target volume, and if the 
density representation of the tumour volume changes as the magnitude of motion 
increases.  
 
2) What impact do different CT numbers derived from reconstructed 4DCT 
datasets have on dose calculated to a point? 
The second aim is to study the accuracy of dose delivery to a point within the moving 
target on the different reconstructed images. Since dose calculation is CT number 
dependent, and the reconstructed images have varying CT numbers, the resultant 
calculated point dose is of interest. The accuracy of the calculated point dose can then 
be compared to the measured point dose under the same motion settings in the phantom. 
 
3) What impact does the different CT numbers derived from reconstructed 4DCT 
datasets have on dose calculated to a moving target volume?  
The third and final aim is to observe the dose distribution to the target volume as 
calculated on the different reconstructed images. In the treatment planning process, the 
dose distribution to the entire target volume, not just dose to a point, is used to assess 
the suitability of the plan for the treatment of the patient. Since 4DCT is primarily used 
for imaging tumours involving motion, it is important that dose calculation on the 
reconstructed image is accurate even as the magnitude of motion of the tumour or 
breathing motion is increased. This study involves comparison of the dose distribution 




image compared to the 4DCT image set to determine the equivalency of the dose as 





2. Literature Review 
2.1 Stereotactic Ablative Radiation Therapy(SABR) 
 
Stereotactic Ablative Radiation Therapy (SABR) also known as Stereotactic Body 
Radiation Therapy (SBRT) is widely used for treatment of early stage or stage I lung 
cancers and oligometastatic cancers. SABR is a method of delivering radiation therapy 
to the patient at very high dose per fraction, but in fewer fractions, compared to 
conventional radiotherapy. As such, it is sometimes also known as Hypofractionated 
SBRT treatment. Conventional external beam radiotherapy (EBRT) typically delivers 
comparatively much lower dose fractions at around 1Gy to 4Gy per fraction, with 1.8Gy 
to 2Gy being the most common. The typical number of fractions range between 10 to 30 
fractions [7]. With SABR however, the doses per fraction are typically greater than 
6Gy, ranging anywhere from 6 – 30Gy per fraction, with number of fractions being 
between 1 to 5 fractions [7]. In this thesis, the term SABR and SBRT will be used 
interchangeably. 
 
When higher dose of radiation per fraction is prescribed to the patient, a higher 
biological effective dose (BED) is also delivered to the patient. The BED, refers to the 
true biological dose delivered to the tumour volume, but is not actually biologically 
equivalent in dose. The BED is a dose value determined by a combination of the dose 
per fraction, the total dose, and the  
𝜶
𝜷
  ratio, which is 3 for normal tissues and 10 for 




  ratio is significantly lower according to a study by Brenner & Hall [8]. 
The significance of this lower 
𝜶
𝜷
  ratio is that appropriately planned hypofractionated 
treatments like SABR would be a suitable course of treatment for patients as there 
would be a high level of tumour control while simultaneously also reduced acute 





According to Casamassima et al [9], who studied the different equivalent BED for 
pulmonary neoplastic nodules, for proper radioablation of the pulmonary neoplastic 
nodule, SABR with high dose fractions and thus high BED is necessary. In another 
study by Mehta et al [10], that studied the radiobiological rational for dose per fraction 
escalation in non-small cell lung cancer (NSCLC), a higher BED delivered within a 
shorter period, like SBRT, achieves better local control of the lung cancer. In another 
retrospective study by Onishi et al [11] of 257 patients with stage I NSCLC in a 
Japanese Multi–institutional study, hypofractionated high dose stereotactic radio 
therapy, similar to SABR, with high BED, is a feasible curative treatment for patients 
with stage I NSCLC. 
 
There have been multiple studies, [9, 10, 11, 12, 13],that have concluded that delivering 
high doses of radiation per fraction such as SBRT is an effective procedure for the 
treatment of early stage cancers, such as stage I NSCLC lung cancers. SBRT provides 
high local control as well as reduced treatment time. To ensure proper and successful 
administration of the treatment, target delineation is essential to ensure that highly 
conformal dose is delivered to the target while healthy normal tissues are spared. This is 
especially important in the case of SBRT treatment as this method requires very high 
radiation dosage per fraction to be administered to the patients. Treatment margins have 
to be within millimeters accuracy with well-defined target definition [7]. Additionally, 
strict motion management is essential as well, especially since one of the major factors 
to account for with lung tumour cancer, is respiration. 
 
In summary, motion management and proper target delineation during treatment 
planning is essential to deliver the highly conformal SABR treatment to patients 
successfully without complications. 
 
2.2 Computed Tomography 
 
Computed Tomography (CT) images are 2D cut plane images formed as a result of 
highly filtered kilovoltage x-rays being transmitted through the body of the patient at 




processing, these transmissions are converted into images which can be used to identify 




 On the CT scanner, the x-ray source is located directly opposite an array of detectors in 
a donut like structure called the gantry. The patient is positioned on the moveable table 
(sometimes known as couch) that goes though the gantry as seen in Figure ‎2.1. The 
detector effectively measures the x-ray intensity transmitted (It) through the patient. 
Unattenuated x-ray beam (I0) is also measured by a reference detector. A single slice 
image is produced when the x-ray source and the array of detectors forms a full 360° 
rotation around the patient. This single slice image contains density information about 
all the structures being imaged.   
 
The obtained raw data from the detector is pre-processed. This is a necessary step 
before image reconstruction such that the dependency of the image is primarily 
dependent on the patient’s anatomic characteristics and less on the machine-dependent 
variables of It and I0 [14]. The relationship between the two variables is given by: 
 
𝐼𝑡 =  𝐼0 𝑒
−𝜇𝑡 
t is the thickness of the patient along the ray, while µ is the average linear attenuation 




) =  𝜇𝑡 
This preprocessing step results in the t variable ultimately cancelling out, producing the 
average linear attenuation coefficient µ used in the CT reconstruction algorithm. 
 
After all data has been pre-processed, it then undergoes CT reconstruction methods to 
produce a CT image. Filtered backprojection is the preferred reconstruction algorithm. 
As the method’s name suggests, this algorithm back projects, or reverses the image 
acquisition process. The attenuation information collected as the x rays transmit through 
the body, is smeared back along the same x ray path on to an image matrix. This process 





The resultant image is the cross-sectional 2D CT image of the 3D structure. Each image 
pixel displays the average x-ray attenuation property of the structure being imaged. 
Areas of high attenuation, where less x-rays are transmitted, will appear lighter (dense 
structures) while areas of low attenuation have more x rays being transmitted and will 




2.2.1 Axial/ Sequential Static scan 
 
Early CT scanners employed a step-and-shoot mode. During the image acquisition 
period, the x-ray tube is turned on and 360 degrees of projection data is acquired. The x-
ray tube is then turned off while the patient is moved to acquire another slice scan. This 
process is repeated until the number of desired scans are acquired. This method is also 
coined the term step and shoot CT due to this process. During the image acquisition 
period when the x-ray tube is turned on, the table is completely stationary [14]. This is 
also known as axial or sequential CT scans. 
 
2.2.2 Helical Scan 
 
The introduction of slip ring technology resulted in the advent of helical CT scanners. 
Helical CT scanners rotate continuously around the patient in a spiral motion as the 
patient is gradually moved through the gantry on a patient couch at a constant speed to 
obtain the CT images. This effectively results in the x-ray tube moving in a spiral or 
helical fashion around the patient. This allows CT images to be acquired continuously 
as the patient table moves inwards through the gantry. Interpolation of data is required 
to estimate the image between the collected and rebinned data [15]. The interpolation is 
necessary such that smooth cohesive images are formed as the patient translates through 
the gantry.  In terms of acquisition time, helical scans are more quickly acquired than 
static axial scans. As seen in Figure ‎2.1, the patient is gradually moved through the 





Figure ‎2.1 Shows how helical scans are taken as the scanner rotates while the patient is simultaneously moved 
through the gantry [16] 
An important parameter that should be considered with helical scanning is the pitch. For 
a conventional helical CT scanner, the pitch is defined as the distance travelled by the 
table per 360° rotation divided by the collimator width [15]. The beam width, which is 
affected by the collimator width also determines the image thickness. Therefore, the 
pitch can also be understood as the ratio of the distance travelled by the table per 
rotation to the slice thickness. The pitch affects multiple factors such as the image 
quality, scan time, and radiation dose to the patient.  
 
When the Pitch = 1, this is ideal where the images are formed exactly where the last one 
started with no gaps or overlaps in the images or x ray beams (comparable with 
contiguous axial CT). A pitch < 1 results in over–scanning. This means that there is 
over lapping in the x ray beams and thus CT images. While the image quality may be 
better, the trade-off is increased scan time as well as increased radiation dosage to the 
patient. A Pitch > 1 means there will be gaps where parts of the structures are not 
irradiated. Partial scanning occurs and more interpolation is necessary. This results in 
faster scan time and less radiation dose to patient. This also means that there is less 
patient motion throughout the scan. 
  
In general a pitch of 1 to 1.5 is considered acceptable to be used [14]. The method of 




however is that there is potentially loss of information during scan acquisition, which 
leads to more reconstructions artifacts than static axial scans. 
 
2.2.3 CT number consistency 
 
CT numbers are normalized integer numbers used to represent the attenuation value 
calculated for each pixel of the CT image produced. It is normalized to the attenuation 
properties of water. It is measured in Hounsfield Units (HU) and is acquired using the 
equation: 
 




           (eq 1) 
Where µ refers to the average linear attenuation coefficient of the structure measured, 
while 𝝁𝒘𝒂𝒕𝒆𝒓 and 𝝁𝒂𝒊𝒓 are the linear attenuations of water and air respectively. The µ 
values are all taken at the same energy. The numbers can range from about -1000 HU to 
+3000HU [14]. Air has a CT number of -1000 HU while water will have a CT number 
of 0 HU at STP (Standard Temperature and Pressure). 
 
CT numbers describe the physical attributes of the structures and how it influences 
Compton scattering [14].Compton scattering is the dominant x-ray interaction in CT 
imaging. This is reflected in the contrast of the CT image (the different shades of grey 
of the CT image). The Compton scatter cross section depends on the electron density 
𝜌𝑒, where 𝜌𝑒 = 𝑁
𝑍
𝐴
 where N is Avogadro’s number (6.023 x 10
23
), Z is the atomic 
number and A is the atomic mass. Different structures in the body like soft tissue, lungs, 
and fat constitute of different proportion of carbon, hydrogen, nitrogen and oxygen. 
Hydrogenous (Z = 1, A = 1) tissues like fat is well visualized on CT images [14]. This 
results in the different structures having different CT numbers. The electron density ρe 
(cm
-3
), measured in number of electrons per unit volume, is different from the physical 
mass density ρ (g/cm3), measured in mass per unit volume.  
 
In Table 2.1 approximate CT numbers for various tissue types are listed. A range of CT 




factors such as different tissue compositions and thicknesses within the patient. 
Different CT scanners also provide CT numbers of varying values. Measuring the CT 
number is an important part of the diagnostic workup and can lead to more accurate 
diagnosis. As an example, the amount of calcification on pulmonary nodules can be 
determined from the CT image by measuring the CT number [14].  
 
Table 2.1 The Table shows the approximate CT numbers of various structures within the body [17]. 
Structure CT Number(HU) 
Bone 700 to 3000 
Soft Tissue -300 to -100 
Blood 35 to 40 
Muscle 40 
Kidney 30 
Fat -50 – 100 
Human Lung -700 
 
To accurately assess the CT numbers from a CT scanner, a CT–density phantom with 
various known tissue densities representing the different areas of the body like lungs, 
water, soft tissue, bone, etc, can be scanned. When the phantom is scanned and the CT 
number (HU) is obtained, a relationship between the various tissues and the CT 
numbers can be established. The CT Electron Density Phantom by Gammex [18], is 
designed for this purpose, and can be used to convert the CT numbers obtained in 
Hounsfield units (HU) to electron densities for accurate calculation of the dose 
distributions. The Solid Water Phantom as seen in Figure ‎2.2 can be equipped with 16 
different inserts with interchangeable Tissue Mimicking Materials (TMM). The 16 
inserts consist of 13 different materials with a wide range of electron density values that 
can be used to obtain a CT–to–density table necessary for calibration. Thus, an accurate 






Figure ‎2.2 The Gammax RMI Solid Water CT Electron Density Phantom with the 16 different inserts of different 
electron density values used for calibration [18]. 
During treatment planning, a CT electron density phantom like the one described above 
is used to calibrate the CT number (HU) and tissue density relationship. Once CT 
images of the calibration phantom are scanned, they are then exported onto treatment 
planning systems like Pinnacle
3
 [19]. On Pinnacle
3
, regions of interest (ROI)s, including 
the inserts with the various different electron densities can be contoured. Pinnacle
3
 will 
then provide the average CT number (HU) for the various ROIs and the contoured 
inserts. The physical mass density (g/cm
3
) of each insert of the phantom, as well as the 
relative electron density to water, 𝜌𝑒
𝑤 is known. Only mass density is recorded on 
Pinnacle
3
, corresponding to the CT numbers obtained. Thus, a CT number calibration 
table can be formed. Pinnacle
3
 is unique, such that the CT number scale goes from 0 to 
4000 instead of starting from -1000 (CT number for air). This is to avoid signed 
integers. Therefore, the final 1000 units need to be added to obtain the final CT number 






Figure ‎2.3 Example of the CT number (HU) to Density (g/cm3) calibration table used in Pinnacle3 
 
The detectors on the CT scanner measures the physical attenuation experienced by the 
phantom, and thus, physical density is used in the CT to Density calibration table 
instead of electron density. An example of the CT to Density calibration table can be 
seen in Figure ‎2.3. Additionally, a dual energy CT is needed to determine the different 
attenuations to obtain the electron densities [20], but this is more time consuming. 





) values for dose calculation. This step is necessary as the 
electron density (cm
-3
) determines the dose deposited in the area due to Compton 
interactions. 
 
Therefore, based on the CT number, it is possible to then derive the properties of the 
material, based on the photon tissue interaction [21]. This information can then be used 
in CT based dose calculations [21]. 
 
2.3 4D Radiotherapy 
 
The gold standard definition of 4D Radiotherapy according to Paul Keall [22], is the 
explicit inclusion of the temporal changes in anatomy during imaging, planning and 
delivery of radiotherapy. For organs that involve a lot of motion like lung radiotherapy, 




motion. While the greatest motion is in the craniocaudal direction, it is not one 
dimensional and is subject to movement in lateral and or anterior/posterior direction as 
well. Therefore prior to treatment, imaging of the treatment site is very much necessary. 
4DCT is usually the best imaging technique where motion is involved, complementary 
to SBRT or SABR treatment. It is the acquisition of a sequence of CT image sets over 
consecutive segments of a breathing cycle [22]. In using 4DCT for imaging, the motion 
of the tumour during respiration can be captured with greater accuracy and fewer 
artifacts, leading to better dose conformality during treatment planning. This simulation 
technique will be further discussed in the next sub chapter. The highly conformal dose 
distribution is designed to target and kill tumour cells while sparing surrounding healthy 
tissues. Before actual radiation therapy is delivered to the patient however, treatment 
planning and or treatment simulation is very much necessary. Using techniques like 
SBRT in 4D radiotherapy for lungs, with proper target delineation, high conformal dose 
can be delivered to the tumour while healthy tissues are spared.  
 
 
2.3.1 Four-Dimensional Computed Tomography (4DCT) 
 
While the discussed 3DCT methods above are excellent and still widely used, a few 
problems or artifacts arise especially when motion is involved. Patient movement, 
especially involuntary motion such as respiration or organ movement can cause motion 
artifacts where the structures imaged would be blurred and or distorted, resulting in 
images that do not correctly reflect the actual structure. CT numbers may be affected as 
well due to beam hardening [23], and partial volume effects [23]. 3DCT images consists 
of only snapshot images at random breathing phases. 
 
4DCT or 4–Dimensional Computed Tomography is a more recent and useful method of 
imaging that has been introduced to account for motion. It is especially useful when 
imaging areas of significant motion like the thoracic area where the lungs and heart are 
located. 4DCT imaging is a simulation technique, where the 4DCT images are an 
extension of 3DCT techniques with the benefit of defining the location of a moving 
organ at a specific time. 4DCT images are a collection of multiple sets of 3DCT images 




complete respiration cycle [24]. The acquired 3DCT images tagged with the breathing 
signals are sorted retrospectively according to the correct breathing phase or motion 
amplitude to provide a full set of 4DCT image [24].The respiration cycle includes the 
start of the inhalation to the end of the exhalation. Effectively the 4DCT images show 
the anatomical position and shape of all the structures and how it moves and changes 
throughout the respiration cycle. 
 
4DCT is used commonly for non-small cell lung cancer (NSCLC) target delineation in 
conjunction with stereotactic ablative body radiotherapy (SABR), also known as 
stereotactic body radiation therapy (SBRT). As 4DCT images provide more 
anatomically accurate images with less blurring and fewer motion artifacts, using these 
images for target delineation of volumes in SABR is preferred. It should be noted that 
the 4DCT imaging technique can also be used in with other forms of non-stereotactic 
treatment fractionation as well. 
 
The image acquisition can broadly be categorized into cine mode and helical mode. 
Cine Mode involves acquiring images using static/axial CT scanning methods while 
simultaneously acquiring patient specific breathing signals. With this method, for at 
least one respiration cycle, the CT scanner continuously acquires images of the patient 
with the patient table being completely stationary. Once the respiration cycle is 
completed, the patient table is moved a distance through the gantry and images are 
taken for the following respiration cycle. The distance moved is equivalent to the 
detector(s) width. This process is repeated for the required number of respiration cycles 






Figure ‎2.4 shows how the 3DCT images are used to form 4DCT image set based on breathing cycle in Cine mode. 
Images can be sorted according to breathing phases as shown in this figure, or by motion amplitude. 
 
The breathing signal can be generated based on using external respiratory tracking tools. 
This usually involves markers being placed on the patient, like a marker block and an 
infrared camera as with the Varian RPM system to track the respiratory motion [25],or 
pressure sensitive pneumatic belts that derives the abdominal motion, like with the 
Anzai(AZ-733V) belt. These systems work to track respiratory motion of the patient 
and sort the images properly according to the retrieved signal. The Varian RPM system 
is discussed further under the subtitle gating with external respiration signal. 
 
 Each of the highlighted region in yellow in Figure ‎2.4 represents a 4DCT image set, 
consisting of sets of 3DCT image taken at multiple phases of a single respiration cycle, 
at a stationary position. The 4DCT scan is complete when the entire structure is imaged, 
and the images can be combined to reflect the motion of the organ or tumour 
corresponding to the breathing patterns of the patient. 
 
Helical mode involves acquiring CT images by helical CT scanning with a small pitch 
in conjunction with the patient specific breathing signal. This method is quicker and 
results in less radiation to patient as the patient is continuously moved through the 




between the data taken. This may result in slight inaccuracies as compared to images 
acquired in cine mode, however the acquisition time is also quicker via helical CT 
scanning. Helical CT scans require an additional breathing cycle scan so that all 
locations have complete breath cycles data for data interpolation [13]. According to 
[14], to ensure that there is no missing data when obtaining images by helical means, a 
data sufficiency condition (DSC) is necessary such that at each table location, data is be 
acquired for the duration of one respiratory cycle, plus the duration of data acquisition 
for image reconstruction. 4DCT is a method of imaging used in many cases today for 
treatment of lung cancers [6, 25, 26, 27, 28, 29],especially where SABR of stage 1 
NSCLC cancers are involved. 
 
2.4 Respiratory Motion Management techniques 
 
While 4DCT imaging is ideal for capturing the motion of a tumour, to obtain good 
quality images, motion management techniques are necessary to reduce motion artifacts 
and decreased dose conformality during treatment. 4DCT images are more prone to 
artifacts when the respiratory cycle or breathing patterns of the patient are irregular [31]. 
Additionally, the motion the tumour obtained during 4DCT imaging and treatment 
planning, may not be the same as the tumour motion during treatment delivery. To 
overcome this, patients are coached to breathe such that a consistent respiratory motion 
can be produced, resulting in better image quality.  
 
 In SABR, to ensure that the high radiation dosage is minimized to healthy lung tissue 
volume, motion management is a very important factor to consider before delivering the 
dose. Intrafraction motion, that is involuntary motion of the patient such as respiratory 
motion, has to be accounted for before dose delivery. Interfraction motion on the other 
hand refers to set up errors that occur when setting up patients for treatment from one 
fraction to the next fraction. That is, patient set up may differ slightly each time. 
 
With lung cancer, of course the main component is the respiratory motion. The lungs 
functions by ventilating the lungs through inhalation and exhalation. The diaphragm 




reducing the density of the lungs. This causes motion in the superior inferior (SI) 
direction of the body, while the rib cage motion causes motion in the lateral and 
anterior–posterior (AP) direction to occur. This effectively causes motion in normal 
healthy tissues, as well as the tumour itself. Every patient will have varying breathing 
patterns pertaining to the period, amplitude, and direction of motion of the tumour. It is 
often difficult to visualize and monitor tumour directly using fluoroscopic or portal 
images during treatment. This prompts the necessity of using surrogates to monitor the 
tumour motion. The surrogates are usually used to provide observation of respiratory 
motion through the diaphragm or chest wall motion, which is an indicator of lung 
tumour motion. However, caution must be taken, as this surrogate tumour motion, may 
not accurately reflect true tumour motion [32].Therefore, individualized respiratory 
motion must be assessed prior to patient treatment.  
 
 
2.4.1 Respiratory Gating 
 
Respiratory gating can be generally classified between gating with an external 
respiratory signal, and gating with an internal respiratory signal. This method usually 
involves only administering radiation treatment at a specific phase of the patient’s 
respiratory signal where the radiation beam is “gated” on, while at other phases, the 
radiation beam is “gated” off.  The patient’s respiratory motion can be observed through 
internal fiducial markers implanted into or near the tumour, or by external respiratory 
signal.  
Gating with Internal Fiducial Markers. 
 
Gating with internal fiducial markers involve implanting small gold fiducial markers of 
about 2mm in diameter, into or around the tumour in question. To properly track the 
motion, a minimum of 3 fiducial markers are necessary. The fiducial marker positions 
are then tracked using stereotactic kilovoltage x-ray imaging systems in combination 
with automatic detection software [32].  Radiation treatment is delivered when the 
position of the fiducial markers are within range of the planned position on the 
stereotactic imaging cameras [32]. The Fiducial markers can be inserted percutaneously 




However, fiducial markers tend to migrate or move around slightly and can even be 
dislodged from their original location. In some cases, it can even lead to pneumothorax, 
that is, a situation with a collapsed lung where air leaks from the lung into the chest wall 
cavity. In a study of 28 patients who have had fiducial markers implanted [33], 67% of 
the patients developed pneumothorax and 22% required a chest tube. Some fiducial 
markers were also found to have migrated into both the pleural and airway space. In 
another study by Mallarajapatna et al [34], of about 122 cases, it showed that fiducial 
markers can migrate into the pleural cavity, the peritoneum, and even in the lung or 
viscera. Two patients had moderate hemothorax. Therefore, caution should be taken 
when using internal fiducial markers. 
 
A more successful and less risky method is to place the fiducial markers via 
conventional and electromagnetic navigation bronchoscopy (ENB) [35]. This technique 
was originally designed for assisting biopsies of intrapulmonary nodules. It does not 
require needle gauges puncturing percutaneously to place the fiducial markers, and thus, 
a significantly lower risk of complications occurring by pneumothorax or bleeding. CT 
images of the lungs and the bronchial tree are taken such that the ideal path to use when 
inserting the probe is known. The ENB thus utilizes electromagnetic fields that 
encompass the entire thorax region to detect and guide the endoscope or catheter 
through the bronchial tree, to the lungs, and to the region of interest [35]. To confirm 
that fiducial markers are properly implemented to the area or region interest, 
fluoroscopy is used to ensure proper marker placement. Inserting fiducial markers via 
conventional or ENB allows for optimized therapy planning as well as reduced risk of 
complications [35]. 
 
Gating with External Respiration Signal 
 
Gating with external respiration signal is less invasive compared to internal fiducial 
markers. Prior to radiotherapy treatment, gated CT scans are obtained. The tumour 
motion is tracked by observing the respiratory motion, by means of external respiration 
signal. The most common method currently to monitor tumour motion and obtain 
breathing signal is by using the Varian Real–Time Position Management
 TM
 (RPM) 




and a marker block (an external surrogate), which is a rectangle box with reflective 
markers (in the form of dots) to track the patient’s motion. 
 
The marker block is placed on the patient’s abdominal area, where it rises and falls as 
the patient breathes. The external rise and fall of the abdominal area reflects the 
movement of the patient’s organs and tumour within the treatment field [25]. The 
position chosen should reflect the maximum AP respiratory induced motion [32].The 
infrared camera tracks this respiration motion by tracking the marker block in 3 
dimensions (vertical, longitudinal and lateral). The infrared camera is composed of a 
video camera attached below a circular array of LEDS that emit infrared light. Since the 
markers are calibrated a distance apart, the absolute motion in the perpendicular plane to 
the camera will be captured. The computer contains a software that detects the peaks 
and amplitudes of the respiratory signals and assigns relative breathing phases based on 
these amplitudes [36].The predictive filter monitors and predicts the patient’s breathing 
pattern [25]. As the camera tracks the movement, a pattern is established and thus a 
trace can be produced. The predictive filter acts by predicting the patient’s breathing 
pattern and continuously verifies that the pattern is being followed. If the pattern is 
changed or interrupted, the predictive filter detects the change and the RPM system 
stops the beam during treatment [25]. The RPM system displays the motion amplitude 
and phase through a graphical user interphase [36]. 
 
With the help of the Varian RPM system, a trace of the respiratory cycle can be 
produced, and CT image acquisition can be acquired either prospectively, or 
retrospectively. Prospective gated CT imaging is a process in which images are acquired 
only at a specific phase, or the gating window, during a respiratory cycle as specified by 
the user. In a process known as retrospective CT imaging however, images are acquired 
throughout all phases of the respiratory cycle and are sorted accordingly.  
 
The Varian RPM Respiratory Gating technology enables synchronization or correlation 
of the tumour position and the patient’s respiratory signal [36]. The process of gating 
enables users to define a specific window wherein processes can be turned on or off 
within that window. During treatment, the RPM system is connected to the computer 
linked to the accelerator, allowing users control or an automated trigger to the 




window. Problems arise however as there are uncertainties when deriving the internal 
tumour position from surrogates. The actual tumour position and marker can vary inter 
and intra fractionally [38], where the surrogate tracked by the gating system, does not 
correspond to the time dependent target position [32]. To ameliorate this, a minimum of 
30 seconds of imaging data should be digitally recorded simultaneously with the 
measured respiratory trace. Should there be a time delay of greater than 0.5 seconds 




2.4.2 Slow CT Scan 
 
Performing slow CT scans is a method used to obtain images to define the entire range 
of motion of the tumour volume. The CT scanner is operated very slowly where 
multiple CT scans are obtained and averaged over the entire respiration cycle. If CT 
scans are obtained helically, a slow gantry rotation speed is necessary such that tumour 
motion is properly captured during image acquisition. This method can be easily 
implemented on most CT scanners without any additional cost or equipment. Patients 
can also breathe freely throughout the imaging process. However, one drawback is the 
loss of image resolution, where the exact tumour shape and shape of the surrounding 
structures will be blurred in the slow CT image. This will lead to larger errors in target 
and healthy tissue delineation [36].  Additionally, slow CT scanning requires a longer 
imaging time, which results in an increased dose to the patient. While Slow CT scans in 
general help show the extent of the tumour motion, standard CT scans are still necessary 
to determine the boundaries of the different anatomies involved. 
 
2.4.3 Breath Hold Techniques 
 
Another method that has been introduced, to deal with respiratory motion is obtaining 
breath hold CT images. This method, as the name suggests, requires coaching of 
patients to voluntarily hold their breath when a scan is taken. However, not all patients 
are able to undergo breath hold CT scans as some may not be healthy enough to hold 




mentioned slow CT scan, if breath hold CT scans are properly obtained, there will not 
be blurring caused by motion. Breath hold techniques are often applied to maximum or 
moderately deep inhalation phases, or at the end of normal exhalation. This ensures 
better reproducibility of the tumour position. Breath hold techniques employing 
datasetss based on both end inhalation and end exhalation can be used to gauge the 
amplitude of motion of the tumour volume [30]. However, tumour position observed 
with breath hold techniques does not always correspond to the position observed with 
free breathing techniques due to the different respiratory muscles used in both methods, 
and any tumour lag that occurs during free breathing CT scanning is not seen with 
breath hold techniques [32]. Active Breathing Control (ABC) is one method of 
producing breath hold CT images. This device consists of a digital spirometer that 
measures the respiratory trace, which is connected to a balloon valve. The patient 
breathes normally through the spirometer, and after taking preparatory breaths, 
instructed to reach a specific lung volume.  The balloon valve is then inflated for a pre-
defined period of time, simulating the patient’s breath hold [30]. This is usually for 
about 15 to 20 seconds. During treatment, the patient’s breathing for this 15 to 20 
second period of time is “held”, while radiation treatment is administered. The radiation 
beam is stopped after that period of time, allowing patients to breathe normally until the 
ABC is activated again.  
 
While breath hold techniques are less suitable for lung cancer patients, they are suitable 
for the treatment of breast cancers as reduced radiation dose is delivered to nearby 
OARs like the heart  [40]. During breath hold, the heart is pushed down, away from the 
radiotherapy fields, reducing risk to healthy OARs without affecting resultant delivered 
dose to the cancer in the breast region [41]. Voluntary breath hold is the most cost-
effective breath hold technique as it reproducibility as well as cardiac sparing effects are 
comparable [41]. This technique effectively reduces treatment related toxicity to the 
patients, that is, reduced toxicity to the heart [40] and surrounding healthy tissue. 
 
2.4.4 Real Time Tumour Tracking 
 
Real time tumour tracking is another means of motion management which, tracks the 




This involves identifying the tumour’s position in real time, anticipating the tumour 
motion and location throughout the treatment time, allowing for time delays when 
repositioning the radiation beam with the help of MLCs, and adapting the dosimetry to 
allow for motion of the tumour and healthy anatomy [32]. Real time tracking of the 
tumour involves imaging via fluoroscopy, imaging of fiducial markers or tracking of an 
active or passive signaling device implanted into tumours. For accurate tracking, the 
imaging should be done at a high frequency of several images per second, to ensure 
accurate tumour location. This information is transmitted to the beam delivery system. 
Time delays need to be accounted for between image acquisition, read out, processing, 
and repositioning of the radiation beam through MLCs on the LINAC. Adaptive filters 
can be applied to account for up to 200ms in system delays, but accuracy tends to 
degrade with longer delay intervals [32]. 
 
Real time Tumour tracking is used by a robotic radiosurgery system, Cyberknife. Using 
a combination of implanted fiducial markers for tumour motion tracking synchronized 
with x-ray imaging, a small linear accelerator attached to a robotic arm will move to 
many non-coplanar positions, determined by a treatment plan. With treatment nozzle 
moving and targeting in synchrony with the moving fiducial markers, radiation is 
continuously administered to the tumour site.  
 
2.4.5 Motion management with 4DCT 
 
In terms of lung cancer and accounting for respiratory and tumour motion, 4DCT, as 
described in a previous section, is ideal in tracking the tumour motion as well as 
producing accurate images of the healthy surrounding anatomy. Based on 4DCT 
images, the tumour volume position as well as the amplitude of motion can be identified 
for treatment planning [33]. Breath hold CT techniques can be employed to obtain 
4DCT images, however free breathing CT is more commonly practiced when acquiring 
4DCT images [42, 43, 44, 45, 46]. Images are acquired retrospectively, that is, acquiring 
images are continuously acquired along the longitudinal length of the patient at every 
phase of the breathing cycle, to then be sorted either according to the amplitude of the 






2.5 Motion Artifacts 
 
Artifacts are usually an error or a distortion to the image that is not representative of the 
actual structure being imaged [47]. This means that on the CT image, there would be a 
discrepancy between the CT numbers of the reconstructed image and the actual 
attenuation coefficient of the actual structure being imaged [47]. Artifacts degrade 
image quality which could lead to errors in target delineation during treatment planning, 
and thus errors in actual treatment. 
 
Motion artifacts are a major and a common occurrence in conventional 3DCT images. 
Motion artifacts are due to patient factors (such as respiration which causes organs to 
shift), as well as target related factors (such as the location and size of the tumour) [48]. 
Motion artifacts lead to images appearing smeared, distorted, or a combination of both. 
Structures contained in the thorax region tend to move periodically in the craniocaudal 
and anterior posterior axes, with a period of ~4 seconds with amplitude of motion being 
in the order of a few centimeters (cm) [49]. Many studies [28, 49, 50, 51, 48], have 
reported that the true anatomical position is not reflected when imaged due to motion, 
causing a need to add an extra margin during target delineation. According to Jiang [24, 
38], if the CT scan speed is slower than the target motion, the target image will appear 
smeared. If the CT scan speed is the same as the target motion, the target position and 
shape will be distorted. However, if the CT scan speed is faster than the target motion, 
the target position and shape will be captured at an arbitrary phase.  
 
While not as prevalent, motion artifacts are known to affect 4DCT images as well [46, 
51, 52, 31]. 4DCT images account for motion where the spatial anatomical position of 
organs at risks (OAR) and tumours are known with relative accuracy. Problems arise 
when the tumour motion is large, or when the patients have irregular respiratory motion 
leading to CT images being tagged incorrectly before being sorted. This results in 
geometric distortions artifacts on the CT images [53]. 
 
Additionally, artifacts can also occur when there is under-sampling of data. When 




necessary. Large motion within a brief time can cause under-sampling of images [46], 
resulting in more interpolation, and thus more uncertainty, leading to artifacts reflected 
on the images. Therefore 4DCT helical scanning requires a small pitch to ensure that 
oversampling occurs to prevent too much unnecessary interpolation. 
 
Another factor which potentially affects 4DCT artifacts is the way in which 4DCT 
images are binned to be reconstructed. When 4DCT images are acquired, they are sorted 
or binned typically by two methods, amplitude binning or phase binning based on the 
breathing signal. Amplitude binning sorts the CT images acquired based on the 
amplitude of motion, and thus, requires a strong correlation between the respiration 
signal and the tumour motion for accurate 4DCT images to be formed. Sometimes due 
to baseline shifts or the uneven breathing pattern, this could lead to missing CT slices, 
which results in artifacts by amplitude binning [54]. In phase binning, images are 
binned into a set number of phase bins, typically 8 or 10 phase bins, equally spaced in 
time. The phase bins correspond to distinct phases in the respiration cycle. Larger 
motion with a short period could result in under-sampling, which would cause more 
artifacts in phase binned 4DCT images [46]. In a recent study conducted by Shieh et al. 
[54], comparing the two respiratory binning methods, it was found that amplitude 
binned images provided better image quality in capturing the respiratory motion than 
phase binned images. Regardless, both methods of image binning are still used in 
practice today for 4DCT imaging. 
 
2.6 4D Treatment Planning. 
 
4D treatment planning is defined as treatment plans designed on CT image sets obtained 
for each phase of the breathing cycle [22]. The first part of 4D planning is acquiring the 
4DCT image. Based on the acquired 4DCT images, the various structures can then be 
identified and delineated. 
 
Accurate target delineation and organs at risk (OAR) definition is especially important 
in treatments like SBRT as this treatment is designed to deliver very high dosage per 
fraction to the patient. As mentioned before, motion is a major factor to consider, and it 




before radiation dose is delivered. In the thorax, the major OARs are lung parenchyma, 
heart, central airway, oesophagus, the spinal cord, the brachial plexus, chest wall, and 
skin [55]. Target and OAR delineation can be contoured and defined on a single image, 
and using deformable image registration, the same contouring can be applied to all other 
images in the different phases of the respiratory cycle [56].  
 
Deformable image registration, is a tool used to map a single moving voxel of the CT 
image onto a new position of the same voxel on another CT image taken at a different 
phase of respiration [22, 56]. The resultant contouring will show how the shape or 
anatomy changes or deforms at different stages of the respiratory cycle. Matching the 
voxels also allows visualization of the dose at each phase of respiration [22]. Some 
algorithms that are commonly used are the finite element method, large deformation 
diffeomorphic image registration, and optical flow technique. The resultant effect 
should be a set of 4DCT images with the tumour and OARs structures properly 
contoured in all phases of the respiration cycle.  
 
Once this is set up, a treatment plan can be made based on the CT images. So far the 
4DCT images that have been defined are snapshot images acquired either in helical or 
Cine mode. There are other types of 4DCT images as well that are commonly used for 
treatment planning.  Maximum Intensity Projection image (MIP) is an image that 
represents the highest density or pixel value encountered along the viewing ray in the 
4DCT image set. This translates to each pixel of the MIP images displaying pixel values 
of the brightest (most dense) object along each ray of the projection image [50]. The 
choice of using MIP image for treatment planning would be better when identifying 
high contrast objects like lung tumours [22].  
 
Another type of 4DCT image is the Average Intensity Projection (AIP) image. This 
image represents the average density or pixel value encountered along the viewing ray 
in the 4DCT image set. Each Pixel of the AIP image displays the average value for all 
the equivalent pixels in the dataset of the object along the ray of the projection image. 
The resultant image, in the case of a moving object, displays the entire range of motion 
of the tumour volume. Relative to MIP images, the borders will appear thicker with 





Physicists also use what is known as the Mid-ventilation image. This method requires 
the reconstruction of a single 3DCT scan from the 4DCT dataset. This image reflects 
the anatomical and tumour position, at its time–weighted average position of the entire 
breathing cycle [42, 58]. The resultant image represents the tumour at its center of 
gravity, in all directions of movement, including anterior/posterior and cradio-caudal 
direction [45, 59]. This image is chosen at the mid ventilation time percentage, which is 
defined as the time at which the tumour is closest to the time weighted mean position 
[42]. Mid Ventilation CT, is an improvement in terms of a reduction in error margin 
[45]. The study by Khamfongkhruea et al. [42] concluded that using the mid ventilation 
concept with the tumour in a mean position, allows for reduced margins [45] during 
treatment planning, leading to more conformal irradiation, reducing the volume 
irradiated [60].   
 
The benefit of using the above 4DCT image type is that it reduces the workload. 
Defining and contouring on a single set of images like the MIP image dataset or the AIP 
image dataset, is much less time consuming than contouring for multiple phases, with 
multiple sets of images [61]. There have been many studies conducted where different 
image types are compared to one another to determine the best image to use for 
treatment planning and dose calculation.  Multiple studies [27, 30, 61, 62, 63], have 
come to the agreement that the MIP image dataset is reliable for target delineation for 
the gross tumour volume of stage I lung cancers, as it clearly highlights the entire range 
of motion of the tumour volume. However, it is also suggested [61] that MIP images are 
not suitable for tumours that are attached to, or intersect any part of the diaphragm. In a 
recent study [65], it was found that 4DCT MIP is useful for establishing the mean 
amplitude of tumour motion before SBRT treatment, however, maximum amplitude 
tends to be underestimated during actual SBRT treatment, and thus caution must be 
taken when determining the various margins during treatment planning, especially in the 
lower lobe region of the lungs. 
 
While MIP images are preferred for target delineation, AIP images seem to be more 
favorable for dose calculation [26, 30, 42]. There is however also a study that suggest 
AIP images are good for both target delineation and dose calculation [61]. In the study 
[61], that compared treatment planning based on MIP, AIP and free breathing CT 




the free breathing image. They also found that MIP images are prone to overestimate 
and underestimate the target volume when the tumour volume is close to denser tissues. 
Additionally, free breathing images are also prone to greater image artifacts than AIP 
images. It was thus concluded in that study [61], that AIP image is suitable for both 
target delineation and dose calculation. Table ‎2.2 shows a summary of the more 
commonly used images reconstructed from the 4DCT image set used in treatment 
planning for patients. 
 
Table ‎2.2:  A table showing some of the different types of images that can be reconstructed based on the 4DCT 
images 
4DCT Image type Description 
Maximum Intensity 
Projection (MIP) 
Image set that represents the highest intensity or highest 
attenuation value of the 4DCT image set. Images are reliable 
for target delineation [26, 30, 44, 58]. 
Average Intensity 
Projection (AIP) 
Image set that represents the average intensity or average 
attenuation value of the 4DCT image set. Images are favoured 
for dose calculation [26, 30, 42, 61]. 
Mid-Ventilation Image 
Image that represents the time weighted average position of 
the tumour volume. Treatment planning with this image type 
leads to improvement in reduction of error margin [45]. 
 
One of the first steps of treatment planning, is to define the structures in general, 
including organs at risk OAR and the tumour volumes. During target delineation, it is 
important to outline the volumes properly and accurately. The International 
Commission of Radiation Units and Measurements (ICRU) has published report 50, 
where they have defined multiple volume types in which doses are to be prescribed and 
delivered. The main volumes defined prior to treatment, are the Gross Tumour 
Volume(GTV), and the Clinical Target Volume (CTV). While performing treatment 
planning, Internal Target Volume(ITV), The Planning Target Volume (PTV), Organs at 
Risk(OAR), Treated Volume (TV), and Irradiated Volume (IR), are defined.  
 
The GTV refers to the palpable visible extent and location of the malignant growth. The 
CTV is defined as the tissue volume that contains the GTV and this volume needs to be 




encompasses the CTV, and accounts for all possible geometric variation with regards to 
the beam size selection such that all the prescribed dose is completely absorbed by the 
CTV [63]. In ICRU report 62, the internal margin (IM) is introduced to account for 
positional and size/shape changes of the CTV. The setup margin(SM) is also introduced 
to account for variations in the patient beam positioning. ( 𝐶𝑇𝑉 +  √(𝐼𝑀)2 +  (𝑆𝑀)2) 
effectively makes up the PTV region. In ICRU report 62, the Internal Target Volume 
(ITV) is also introduced, which is defined as the summed volume of CTV and IM (CTV 
+ IM), and is located within the PTV. The Treated Volume (TV) is the treatment 
planned volume to receive the dose selected and specified by the radiation oncologist. 
The TV encompasses the PTV. The Irradiated Volume (IV) is the tissue volume that 
receives a dose considered significant relative to normal tissue tolerances. These 
Volume definitions are standards that are widely used and widely accepted. Figure ‎2.5 
shows a representation of the different volume definitions used during treatment 




Figure ‎2.5 A representation of the definition of the different volumes during treatment planning 
Since tumour motion is a major source of uncertainty in defining the GTV, the ITV is 
thus necessary to obtain a spatially correct volume for the entire volume of the moving 
tumour. Using a single set of images like AIP or MIP images to represent the various 




ten or eight breathing cycles. While in literature there have been mixed opinions about 
the best image to use for target delineation, mostly between MIP or AIP images, 
regardless of the image type used, proper target delineation is very important to ensure 
conformal radiation and sparing of normal healthy tissues.  
 
Table ‎2.3 The table summarizes the volumes used when contouring the various volumes during treatment planning 
[64] 









The volume that contains the GTV that needs to be treated 
with an adequate dose level. 
Internal Target 
Volume(ITV) 
The summed volume of the CTV and the Internal margin to 
account for physiological involuntary motion. (ITV+CM) 
Planning Target Volume 
(PTV) 
The volume that encompasses the CTV, accounting for 
geometric variations. (ITV+SM) 
Internal Margin(IM) Volume to account for physiological involuntary motion of the 
patient, causing CTV motion. 
Setup Margin(SM) Volume to account for patient setup variation such as patient-
beam positioning. 
Treated Volume(TV) Volume that receives the dose as specified by the radiation 
oncologist to achieve the purpose of the treatment. 
Irradiated Volume(IV) The tissue volume that receives a dose that is considered 
significant compared to normal tissue tolerance. 
Organs at Risk (OAR) This are healthy nearby organs that are susceptible to 
radiation, that also act as constraints 
 
Proper treatment planning and motion management is essential before radiation 
treatment is delivered to the patients. Radiation treatment, especially treatments like 
SBRT that utilizes high radiation doses per fraction requires careful planning such that 
maximum dose is delivered to the patient while simultaneously avoiding normal healthy 




motion as it would be able to properly capture the tumour motion, with fewer artifacts. 
However, care must be taken such that a suitable image type is chosen during treatment 
planning for target delineation and dose calculations. While the different image types of 
MIP or AIP or even a random phase in the 4DCT image can be used for treatment 
planning, depending on the purpose and site of the tumour volume, the most suitable 
image to be used might vary between sites. The choice of image to use for target 
delineation and dose calculation could be different as well, however careful 
consideration should be taken such that there is not excessive workload necessary 
during treatment planning. To deliver precise conformal dose to the patient, careful 
treatment planning is necessary such that cancerous tumour cells can be eliminated and 
healthy tissues are spared.  
 
CIRS Dynamic Thorax Phantom  
 
The phantom of choice that is used for this study during 4DCT acquisition and 
treatment planning, is the CIRS Dynamic Thorax Phantom. This phantom provides an 
accurate representation of the composition, shape, and density of an average human 
thorax. It is designed to also provide and simulate various complex 3D motions that 





Within the phantom are two lung equivalent lobes. Within one lobe is a long detachable 
lung equivalent rod with a small cylindrical slot where a spherical tumour target and/ or 
a dosimeter can be placed. Various types of rods are available to allow for use with 
different imaging techniques as well as dosimeters. The lung equivalent rod is attached 
to a motion actuator box that has the capability of simulating movement in three 
different axes to simulate target motion [66]. The motion includes inferior/superior 
motion with a maximum of 50mm, anterior/posterior motion with a maximum of 10mm, 
and left/right movements with a maximum of 10mm, or a combination of various of the 
motion [67]. As seen in Figure ‎2.6, the motion of the target motion within the lung 
equivalent rod is illustrated. 
 




The range of motion in any direction is user specific. As the rod is lung equivalent, it is 
radiographically invisible, and simulation of motion will only show motion of the 
spherical target and or dosimeter. As such target motion of the tumour can be easily 
monitored during treatment planning. 
 
Surrogate motion is also provided by using a platform attached to the actuator box as 
seen in Figure ‎2.7. This allows the phantom to simulate the movement of the chest wall 
or the diaphragm, depending on how the platform is positioned. Target and surrogate 
motion are both independent of one another and is controlled by CIRS Motion Control 
Software. Maximum surrogate motion is 50mm. The minimum cycle time is 1 
second/cycle while maximum cycle time is unlimited[59].  
 
Figure ‎2.7 CIRS Phantom Actuator box. The left positioning simulates Chest wall motion while the Right side 
simulates Diaphragmatic motion[58] 
 
CIRS Motion Control Software.  
 
The CIRS Motion control software allows control of the CIRS Dynamic Thorax 
Phantom. It allows user to define the desired motion in multiple directions that simulate 
the motion of a typical patient, all from a laptop with the software installed. 
 
The software allows users to operate the phantom by allowing the user to define 
different wave forms, cycles, phase shifts and amplitude of motion for the phantom.  As 
seen in Figure ‎2.8, the software provides real-time graphic display of the target as well 




any time, which makes it easy for users to conduct both dynamic and static scans on the 




Figure ‎2.8 CIRS Motion Control Software GUI which allows users to input multiple parameters to simulate desired 




3. CT number constancy 
3.1 Introduction 
 
CT images are cross sectional images formed based on x-ray transmissions or projections through 
the body. The CT image reflects the electron density of the structures or tissues imaged within the 
body or phantom. The CT image is composed of a matrix of pixels, where each of the pixel on the 
CT image, corresponds to a specific CT number. The CT numbers are measured in Hounsfield Units 
(HU). The CT number is used by CT scanner to describe how much radiation is attenuated to that 
point or by that structure, relative to water. This value is thus highly dependent on the attenuation 
coefficient of the material, which in turn is dependent on the density and atomic number (Z) of the 
material being imaged.  Knowing the value of this, and comparing it to known CT numbers, we can 
identify the structure being imaged. The CT numbers for air at STP is known to be -1000 HU, while 
for water, it is at 0 HU. 
 
A more detailed explanation of how the CT image is formed, and how the CT numbers are acquired, 
is explained in the earlier Literature Review chapter. Once the CT number from the CT scanner is 
obtained, they can then be converted to the electron densities, which can then be used for calculation 
of the dose distribution to the volume. Therefore, the accuracy of the CT numbers obtained from the 
CT scanner has an impact on the accuracy of dose calculation to patient tumours and OARs. 
 
In this study, 4DCT images are acquired during free breathing from the CT scanner, where images 
are binned according to 8 different phases following the respiration cycle. Based on the acquired 
4DCT images, Maximum Intensity Projection (MIP), and Average Intensity Projection (AIP) are 
formed. Treatment planning on every image of all 8 phases of the 4DCT image set can be time 
consuming, and as such, various image reconstruction methods are implemented to reduce the 
workload. The MIP image is formed based on the maximum intensity or pixel of all phases of the 
4DCT images, projected on to a new image set. Similarly, AIP images show the average intensity or 
pixel of all phases of the 4DCT images. This study involves comparisons of images from MIP, AIP 




the free breathing dataset at approximately midway between two extremes of the respiratory motion. 
As seen in Figure 3.1, where images are binned into 8 different phases, 10% phase corresponds to 
peak exhalation (and the start of inhalation), and the 47% phase corresponds to approximately peak 
inhalation(and the start of exhalation). 
 
 
Figure 3.1 A representation of how the 8 phases of the image sets are binned according to the breathing signal. 
On the various images, the density or the representation of the tumour volume will be very different. 
For example, MIP images will show a clearer, well defined tumour volume throughout the range of 
motion. The AIP image however will show a blurred image, with a less well-defined tumour volume. 
Therefore, the resultant CT number between the various image types would be different as well. It is 
expected that the AIP image will have lower CT number, compared to the MIP, and 23% phase 
image. This is because some lung volume, which is of lower density and thus CT number will be 
averaged during the image reconstruction process as well. 
 
CT numbers can be measured and used to distinguish between the healthy and infected tissues. 
However, CT scanner manufacturers recommend that unless the distinction or contrast is large, the 
CT number alone should not be used to differentiate between the tissue type [68]. CT numbers are 
quickly acquired during the treatment planning process.  In this study, Pinnacle
3




planning. Regions of interests (ROIs) are contoured on the CT image. Each voxel on the CT image 
has a unique CT number, and an average CT number will be calculated and assigned for the entire 
contoured ROI. The CT number is CT scanner specific. A look up calibration table is available on 
Pinnacle
3
 as seen in the earlier chapter, in Figure ‎2.3, that directly converts the acquired CT number 
(HU) into physical density (g/cm
3
). This lookup calibration table is specific to a CT scanner and 
operational energy. Therefore, if images are taken at different times or with different CT scanners, 
there will be variations in the CT numbers as well. Based on the values thus, the physical densities 
(g/cm
3
) can be converted to electron density (cm
-3
), necessary for dose calculation. Therefore, to 
ensure accurate dose calculation, it is important that the acquired CT number is also accurate. 
 
This chapter will focus on evaluating the accuracy of the CT numbers obtained based on the various 
reconstructed images from different 4DCT image set, and how accurate they are as CT numbers will 
affect dose calculations. Planning on the reconstructed image instead of every phase of the 4DCT 




When structures are imaged on CT scanners, the resultant CT image is a representation of the 
densities or linear attenuation by the structures being imaged. Each pixel of the CT image represents 
a voxel element, which reflects the x ray attenuation properties of the structure being imaged. This 
property is then recorded as CT numbers from the CT scanner, which can then be converted to 
physical densities. Based on 4DCT images, different types of images can be reconstructed since 
contouring on every phase of the 4DCT image set can be time consuming.  Each of these image 
types will reflect the structures differently, especially when tumour motion is involved.  
 
In this chapter, the aim is to study how different reconstructed 4DCT image types, specifically MIP, 
AIP, or free breathing image, will affect the resultant CT number of the contoured tumour volume on 
the image. Based on the CT number then, the physical density of the contoured tumour volume can 




study, the image type that best represents the tumour volume can be determined. This is also 




3.3.1 CIRS Phantom and CIRS motion control software 
 
The CIRS phantom as seen in Figure 3.2 is used to acquire the images of the tumour moving at 
various amplitudes. In all the images acquired, the lung equivalent rod of the CIRS phantom was 
equipped with a spherical tumour of 3cm. The lung equivalent rod, attached to an actuator box is 
capable of simulating tumour motion in the superior/inferior (SI) direction, anterior/posterior 
direction, left/right direction, or a combination of more than one direction. The phantom was set to 
only move in the SI direction for 10mm, 20mm , 30mm and 40mm. Another set of images were also 
taken for both AP and SI motion, with AP motion set to 10mm, while SI motion is set to 10mm, 20, 
30mm, and 40mm.  
The CIRS Motion Control (Figure 3.2) allows users to independently control the surrogate motion 
(chest or diaphragm motion) and target motion independently. The surrogate motion was controlled 
by using a surrogate platform, where the reflective marker block was placed, with motion captured 
by the infrared camera. The setup for surrogate motion was in the AP direction, to simulate the chest 
wall motion. Cycle time or period of motion can also be selected for motion of the tumour. In this 




 Treatment Planning System. 
 
The treatment planning system used to observe the CT images was the Philips Pinnacle
3
 treatment 
planning system. Images obtained from the CT scanner were exported to the treatment planning 
system (Figure 3.3) where Region of Interests (ROIs) can be contoured. On the Pinnacle
3
 treatment 




conjunction with the model-based segmentation (MBS) [69] to help radiation oncologists contour 
various volumes. It is a threshold based contouring tool that identifies specific threshold values, and 
contours the ROIs based on the differences in the gradient between structures. This method did not 
impose any constraint on the resultant shape of the delineated object but work only using the 
intensities of the image as a threshold [69]. The “auto-contouring” option allowed multiple images 
containing the same ROI to be contoured at the same time, reducing the workload of contouring on 
all images manually. Based on the ROIs, the average CT number and thus the physical densities 
could be determined. The lookup calibration table (Figure 3.4) allows users to quickly determine the 
corresponding physical density of the ROIs imaged. 
 
The CT number scale shown on Pinnacle begins from 0 instead of -1000. This is to avoid signed 
integers, and thus the final CT number in Hounsfield units needs to be subtracted by 1000 units. 
 
 
Figure 3.2 : The setup for image acquisition. The CIRS dynamic motion controller, operated through the CIRS Motion Control 
Software, supplies motion information, while the Varian RPM system with the Infrared Camera and Marker block captures the motion 





Figure 3.3 : The Pinnacle3 Treatment planning system where various volumes can be contoured on to the images and analysed. The 
circular orange line outlines the tumour volume on the AIP image.  
 







Free breathing scans and 4DCT scans of the CIRS Dynamic Thorax phantom (Figure 3.2) were 
taken using the Siemens CT scanner at the Illawarra Cancer Care Centre (ICCC). In all the images 
taken, the lung equivalent rod of phantom was equipped with a 3cm tumour volume to be imaged.  
 
Helical scans were obtained with the tumour volume set to be moving at various amplitudes, in the 
superior/inferior (SI) motion, anterior/posterior (AP) motion with varying periods. Tumours tend to 
move more significantly in the SI motion, especially those located at the lower lobes of the lungs 
[47, 70]. However, the direction of motion is also dependent on the location and size of the tumour, 
as well as the respiratory pattern of the patient. In the lungs, tumour motion is mainly respiration 
induced and has been found to be mainly caused by the movement of the diaphragm [47], which is in 
the SI direction. Respiratory motion is also the lateral direction. However, this motion is less 
significant compared to SI and AP motion.  
 
The slice thickness for the CT images was set at 2mm thick per slices. The tube current (mA) was 
modulated such that where there was increased attenuation, the current was increased, and current 
was decreased with lower attenuation regions. In this study, we manipulated the SI motion the most, 
varying the motion from 10mm (±5mm), 20mm (±10mm), 30mm (±15mm) and the greatest 
amplitude being 40mm (±20mm ). AP motion was left at either 0mm or changed to 10mm(±5mm) in 
amplitude. These measurements were taken at different periods as well (3 seconds, 5 second and 10 
second periods). For 10 second periods, slow gated scan protocols were used. Increasing the tube 
current, as well as the scan time will help improve the image quality. However, this will also mean 
increased dose to the patient. For this reason, the tube current was automatically modulated to 
increase at regions of high attenuation and decrease at areas of low attenuation. 
 
With slow gated scans, the current was at 40mA. Slow gated scans, as the name suggests, required a 
longer acquisition time. The couch was moved more slowly through the gantry to ensure that 
sufficient time was given to obtain the anatomical cross section of the patient during the respiratory 




taken with a current of 80mA. Normal non-gated scans were taken at approximately 200mA. The 
normal gated and non-gated scans take the same amount of time to be scanned. Static scans were 
also taken for when the phantom is stationary (not moving), where there is no tumour motion.  
 
Table 3.1: The table shows the 4DCT scans acquired corresponding to the amplitude and period used in each of the scan sets. 
Name Period(s) SI(mm) AP(mm) 
CIRS Motion P3s SI 10mm 3 10 0 
CIRS Motion P3s SI 20mm 3 20 0 
CIRS Motion P3s SI 30mm 3 30 0 
CIRS Motion P5s SI 10mm 5 10 0 
CIRS Motion P5s SI 20mm 5 20 0 
BCRPM 001 5 30 0 
CIRS Motion P5s SI 40mm 5 40 0 
BCRPM 002 5 40 0 
CIRS Motion P10s SI 10mm 10 10 0 
CIRS Motion P10s SI 20mm 10 20 0 
BCRPM014 10 30 0 
CIRS Motion P10s SI 40mm 10 40 0 
BCRPM 003 3 10 10 
BCRPM 004 3 20 10 
BCRPM 005 3 30 10 
BCRPM 006 5 10 10 
BCRPM 007 5 20 10 
BCRPM 008 5 30 10 
BCRPM 009 5 40 10 
BCRPM 010 10 10 10 
BCRPM 011 10 20 10 
BCRPM 012 10 30 10 




BCRPM014 10 30 0 
 
The magnitude and period of target motion for all sets of scans taken are seen in Table 3.1. As seen 
in the table (Table 3.1), some of the datasets are named starting with ‘CIRS Motion.’, while some 
others are named starting with BCRPM. The difference is due to the different time the scans are 
taken. Additionally, it was easier to distinguish between the different datasets. All plans with names 
starting with ‘CIRS Motion.’ do not have AP motion. With the exception of ‘BCRPM 001’, 
‘BCRPM 002’, and ‘BCRPM 014’, all other plans starting with ‘BCRPM…’ had AP motion. An 
example of the breathing trace for the tumour motion is shown in Figure 3.5. 
 
Figure 3.5 Representation of the tumour motion during respiration on the CIRS phantom with a period of 10 seconds for each 
breathing cycle, going from the start of inhalation, to the end of exhalation at 0mm displacement, to the next 0mm displacement. In 
this figure, the displacement is in both the Superior/Inferior(in blue) and Anterior/Posterior(in orange) direction. In this study, this 
represents the motion for BCRPM 013. 
 
The RPM system was used to monitor and obtain the breathing signal. The reflective marker block 
was placed on to the moving platform of the CIRS Dynamic Thorax Phantom, which provides 
surrogate breathing motion when placed on the chest wall. The infrared tracking camera emits 






























that tracked the motion of the marker block and produced a trace of the respiratory signal. The 
retrospectively acquired images are then binned according to 8 different equally spaced phases of the 
breathing cycles, at 10%, 23%, 35%, 47%, 60%, 72%, 85%, and 97%. The 8 phases are actually 
taken at increments of 12.5%, starting from 10%. However, only whole integers are allowed on the 
scanner and the additional decimal is not seen on the different phases. Throughout the text, 23% is 
sometimes referred to as 22% as well, and they represent the same phase, which is the phase at 
which the tumour is located midway between the two extremes of tumour motion during respiration. 
Figure 3.6 shows the how the aforementioned phases make up a respiratory cycle, represented by a 
single blue section, the exhalation respiratory section, and a green section, the inhalation respiratory 
section. 
 
Figure 3.6 : A representation of the 8 phases in the respiratory cycle in which the images are sorted and binned to for the 4DCT 
image set. The Green represents inhalation, while blue represents exhalation.  
The CIRS Dynamic Motion Controller (Figure 3.2), through the CIRS Motion Control Software 
sends information to the actuator about the range and direction in which the tumour volume is to be 
moved as specified by the user. Once this was set up, the CT scanner was used to acquire CT scans 
of the phantom. 
 
Images were then DICOM exported onto Pinnacle
3
 where treatment planning is carried out. ImageJ 




4DCT image set was assigned onto a new CT image at the same location. This was done for all 
pixels in the 4DCT image set, effectively forming a new image displaying the maximum intensity 
projection (MIP) CT image. The same process was done to produce average intensity projection 
(AIP) CT images, but with the average of the pixels instead. The images were then exported onto 
Pinnacle
3
 as well. On all the plans listed in Table 3.1, the tumour volume was delineated on all 8 
phases of the 4DCT images, as well as on the AIP and MIP images. Additionally, lung, bone and 
soft tissue regions were also delineated. On the static image however, the 3cm sphere used as the 
tumour was not present. Instead, for comparison, the soft tissue values for the contoured regions 




, the ROIs were selected using the Auto-Contour option, to delineate the regions of 
interest. The Auto-Contour thresholding window was set between a lower threshold of 800 and 
upper threshold of 4096. As mentioned earlier, to avoid signed integers, the final CT number 
displayed on the Pinnacle
3
 treatment planning system had to be subtracted by 1000 HU. The images 







Figure 3.7 The CT number of the various volumes as computed on Pinnacle3 treatment planning system. The final value has to be 
subtracted by 1000 HU 
As seen in Figure 3.7, Pinnacle assigned the average CT number of the contoured volume for the 
tumour volume at each phase, and for lungs, soft tissue, and bone. 1000 HU was subtracted from the 
shown CT numbers, and using the calibration table in Figure 3.4, the obtained CT numbers were 
converted to physical density values (g/cm
3
). This is done on an Excel spreadsheet for all the 
datasets. Of interest, was the CT number(HU) and density values (g/cm
3
) tabulated for the AIP and 




Table 3.2 shows the resultant CT number, subtracted by 1000HU and the corresponding physical 
density values for the moving target at various magnitudes of motion as obtained from the Pinnacle
3
 





Table 3.2: Results comparing the CT number for free breathing, MIP and AIP for the CT number and the corresponding density 
values for the moving target within the phantom. 
Plan Name CT numbers (HU)  Density (g/cm
3
) 
  23% MIP AIP 23% MIP AIP 
static -15.2 1.0 
CIRS Motion P3s SI 10mm -47.4 37.1 -138.2 0.95 1.04 0.86 
CIRS Motion P3s SI 20mm -74.8 31.3 -358.5 0.93 1.03 0.64 
CIRS Motion P3s SI 30mm -81.9 31.5 -477.2 0.92 1.03 0.52 
  
   
   
CIRS Motion P5s SI 10mm -29.4 36 -179.9 0.97 1.04 0.82 
CIRS Motion P5s SI 20mm -37.2 36.9 -324.2 0.96 1.04 0.68 
BCRPM 001 -84.5 34.6 -404.3 0.92 1.04 0.60 
CIRS Motion P5s SI 40mm -74.9 31.1 -459.6 0.93 1.03 0.54 
BCRPM 002 9.1 32.2 -459.7 1.01 1.03 0.54 
  
   
   
CIRS Motion P10s SI 10mm -34.4 37.7 -186.6 0.97 1.04 0.81 
CIRS Motion P10s SI 20mm -36.2 35.1 -319.8 0.97 1.04 0.68 
BCRPM014 11.3 37.3 -401.8 1.01 1.04 0.6 
CIRS Motion P10s SI 40mm -103.8 29.7 -456.9 0.90 1.03 0.54 
  
   
   
BCRPM 003 14.7 38.5 -257.6 1.02 1.04 0.74 
BCRPM 004 11.3 35.3 -346.7 1.01 1.04 0.65 
BCRPM 005 3.3 28.3 -371.9 1.00 1.03 0.63 
  
   
   
BCRPM 006 14.4 40.1 -255.6 1.02 1.04 0.75 
BCRPM 007 13.6 37 -382.5 1.02 1.04 0.62 
BCRPM 008 14.7 35.2 -451.3 1.02 1.04 0.55 
BCRPM 009 7.7 31.4 -465.1 1.01 1.03 0.54 
  
   
   
BCRPM 010 17.4 39 -296.3 1.02 1.04 0.71 
BCRPM 011 16.3 37.2 -345.1 1.02 1.04 0.66 
BCRPM 012 14.3 34.9 -451.2 1.02 1.04 0.55 






As seen in Table 3.2, the CT numbers of the various reconstructed image types were very different. 
The static image produced a CT number of -15.2 HU with a corresponding density of 1.0 g/cm
3
 for 
soft tissue. As there is no motion involved in the static case, the CT number and physical density 
values obtained in the static case provides a baseline for comparison when motion is involved for the 
various delineated volumes. The static image involved taking non-gated axial CT scans taken with 
no respiratory motion set for the tumour motion. When the phantom was imaged for the static scan, 
the spherical target volume was not available. As such for the static scan, the reading for soft tissue 
is used as a substitute for comparison with the target volume instead since the target and soft tissue 
are made of the same material, and thus have the same density. 
 
Based on the results obtained for the CT number and tumour motion as seen in Table 3.2, the 
physical density values for the moving target obtained based on the free breathing image obtained at 
23% phase, and the MIP dataset is similar, regardless of the period or magnitude of motion. The free 
breathing image provided physical density values ranging from the lowest of 0.9 g/cm
3
 to the highest 
of 1.02 g/cm
3





comparison to the expected 1.0 g/cm
3
 expected value, the difference was minimal. However, the CT 
numbers showed greater differences in values. The CT numbers vary more with the ‘CIRS Motion...’ 
dataset, while they do not vary so much with the ‘BCRPM...’ set. All ‘CIRS Motion... ’datasets also 
appear to have negative values, whereas the ‘BCRPM…’ set showed low positive CT numbers. In 
both cases the CT numbers decreased as amplitude is increased. 
 
The AIP image produced showed the lowest CT numbers, with all resultant images producing CT 
numbers in the negative range as seen in Table 3.2. The corresponding density values also showed 
the lowest values for the target volume, based on the AIP image. As the amplitude of motion is 
increased, the corresponding CT number decreased in value. Similarly, the physical density values 
decreased as well with decreasing CT number. The CT number for the moving target volume was 
calculated to be as low as -499.9 HU to a maximum of -138.2 HU. The density value also ranged 
from as low as 0.5 g/cm
3








Figure 3.8 : Density comparison at a period of 3 seconds with amplitudes of 10mm, 20mm, and 30mm, with just SI motion 
 
 
Figure 3.9: Density comparison at a period of 5 seconds with amplitudes of 10mm, 20mm, 30mm, and 40mm with just SI motion 
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Density Comparison with period of 3 seconds 
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Density Comparison with Period of 5 seconds 





Figure 3.10: Density comparison at a period of 10 seconds with amplitudes of 10mm, 20mm, 30mm, and 40mm with just SI motion 
 
Figure 3.11 : Density comparison at a period of 3 seconds with amplitudes of 10mm, 20mm, and 30mm for SI motion, and AP motion 
of 10mm 



























Density Comparison with Period of 10 seconds 
MIP AIP Free Breathing static
1.04 1.04 1.03 
0.74 
0.65 0.63 



















Density Comparison with AP motion with Period of 3 
seconds 





Figure 3.12: Density comparison at a period of 5 seconds with amplitudes of 10mm, 20mm,30mm and 40m for SI motion, and AP 
motion of 10mm 
 
Figure 3.13 :  Density comparison at a period of 10 seconds with amplitudes of 10mm, 20mm,30mm and 40m for SI motion, and AP 
motion of 10mm 
In the graphs shown in Figure 3.8, Figure 3.9, Figure 3.10, Figure 3.11, Figure 3.12¸and Figure 
3.13, the graphs compare the different calculated densities of the moving target at different periods 























Density Comparison with AP Motion with Period of 5 
seconds 
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Density Comparison with AP motion with Period of 10 
seconds 




and magnitudes of motion for MIP, AIP and free breathing, relative to when the target is static. 
Figure 3.8,Figure 3.9, and Figure 3.10, compared the density of the moving target with only SI 
motion, at period of 3, 5 and 10 seconds, respectively, while Figure 3.11, Figure 3.12, and Figure 
3.13 compared the density of the moving target with both AP and SI motion at 3, 5, and 10 seconds 
respectively. Based on the graphs, the AIP image represents the target volume with the lowest 
density value, in comparison to the other plans. The other plans however showed comparable results 
to one another, where the density of the moving target calculated at the different periods and 
amplitudes of motion is similar to the measured density when the target is static. 
 
Table 3.3 shows the obtained CT number and corresponding density values different OARs at varying amplitudes and period of 
motion obtained from Pinnacle3 for the 4DCT image set, but not of the MIP or AIP datasets.  
Plan Name CT numbers (HU)  Density (g/cm^3) 
  bones soft tissue lung bones soft tissue Lung 
static 369.9 -15.2 -800.4 1.23 0.99 0.20 
CIRS Motion P3s SI 10mm 354.7 -17.2 -800.2 1.22 0.98 0.20 
CIRS Motion P3s SI 20mm 350.5 -18.3 -798.4 1.35 0.98 0.20 
CIRS Motion P3s SI 30mm 336.0 -14.3 -796.2 1.34 0.99 0.21 
        
CIRS Motion P5s SI 10mm 358.1 -18.3 -798.5 1.22 0.98 0.20 
CIRS Motion P5s SI 20mm 360.1 -16.4 -798.3 1.23 0.98 0.20 
BCRPM 001 362.1 -16.3 -799.5 1.23 0.99 0.20 
CIRS Motion P5s SI 40mm 348.4 -17.4 -798.6 1.22 0.98 0.20 
BCRPM 002 348.4 -17.4 -798.6 1.22 0.98 0.20 
        
CIRS Motion P10s SI 10mm 360.8 -17.8 -798.4 1.23 0.98 0.20 
CIRS Motion P10s SI 20mm 353.1 -16.6 -798.0 1.22 0.98 0.20 
BCRPM014 329.9 -16.3 -799.4 1.21 0.99 0.20 
CIRS Motion P10s SI 40mm 349.3 -17.7 -800.5 1.22 0.98 0.20 
        
BCRPM 003 345.6 -16.6 -799.3 1.22 0.98 0.20 
BCRPM 004 366.2 -18.2 -799.9 1.23 0.98 0.20 
BCRPM 005 348.9 -17.3 -801.2 1.22 0.98 0.20 
        
BCRPM 006 349.6 -17.5 -800.1 1.22 0.98 0.20 
BCRPM 007 356.5 -16.5 -799.5 1.22 0.99 0.20 




BCRPM 009 362.0 -17.7 -801.2 1.23 0.98 0.20 
        
BCRPM 010 350.5 -17.5 -800.3 1.22 0.98 0.20 
BCRPM 011 349.8 -16.7 -799.1 1.22 0.98 0.20 
BCRPM 012 362.2 -17.8 -800.2 1.23 0.98 0.20 
BCRPM 013 343.2 -17.1 -798.7 1.22 0.98 0.20 
 
Comparisons for the bone, soft tissue, and lung CT numbers and corresponding physical density at 
the different periods and magnitude of motion was also made as shown in Table 3.3. The values in 
Table 3.3 show the CT number for the 4DCT dataset, before they were processed to become AIP or 
MIP datasets. They are obtained to observe if there are any changes in the density values as the 
amplitude and period of motion of the target volume is manipulated. Regardless, the values should 
show little difference as the bone, soft tissue and highlighted section of lungs do not move much 
throughout the imaging process. The CT number comparison for the bone, lung, and soft tissue 
showed similar numbers throughout the plans. Almost all plans showed the similar physical density 
value for bone, lung, and soft tissue.  
 





 compared to the static plan at 1.23 g/cm
3
. Similarly, the soft tissue density value 
obtained for all plans were the same as the static plan, at 0.99cm
3





. While the lung density for all plans including the static plan was found to be 0.2 
g/cm
3
. The CT number calculated for the bone, soft tissue and lung delineated volume fluctuated 
very little compared to the moving target. In the delineated regions for bone, lung and soft tissue, 
there is no significant motion involved, and thus, the result of similar CT number and density values 




The difference between the reconstructed images of MIP, AIP and free breathing is obvious based on 






Figure 3.14 Compares the difference in images for MIP, AIP, and the 22% phase snapshot, taken from the BCRPM 005 plan from 
Pinnacle. 
 
As seen in Figure 3.14 that compares the difference in the delineated volumes, the MIP image has 
the clearest representation of the contoured target volume. The MIP image reflects a homogenous 
distribution of the same density throughout the contoured volume. The AIP image however showed 
less well-defined borders, with higher densities or intensities shown in the middle of the contoured 
volume. Since the AIP image is formed based on the average intensity across the same point on all 
the 4DCT image set, the resultant image will show the greatest intensity at the point where the target 
is most as it travels across the contoured volume. Additionally, as lung volume is being averaged as 
well, the resultant image showed a blurred target volume, as well as much lower CT numbers. As the 
amplitude of motion is increased, more lung volume was being included in the contoured volume. 
This explains the decreased CT number with increasing target motion on the AIP image especially. 
However, the AIP image does show a good representation of the average density of the moving 
target throughout the respiratory cycle.  
 
Similarly, since the formation of MIP image is based on taking the maximum intensity across all sets 
of the 4DCT images, as the target moves across the lung volume, the resultant image was a 
homogenous target volume represented on the MIP image. Even as the amplitude of motion was 
increased, the image still showed a homogenous image formed. While the corresponding CT number 




image was the greatest of the different types of reconstructed images. While the CT number of the 
contoured target volume was larger than the CT number obtained based on the static target volume, 
however the corresponding density of the target volume was similar. 
 
The free breathing image showed CT numbers that fluctuate more significantly than the MIP image 
CT numbers, as seen in Table 3.2. However, the density values are comparable to that obtained 
based on the free breathing image. The density values however do fluctuate more with increasing 
amplitude. The free breathing dataset represents the tumour volume at a particular phase. The free 
breathing dataset represents the actual shape and size of the tumour as it moves throughout the lungs 
during respiration, compared to MIP and AIP. It should be noted that the static image dataset is not 
the same as the free breathing image dataset. The static dataset represents a stationary target, 
whereas the free breathing dataset represents the target at approximately the midpoint of its motion. 
  
Based on the results, target motion did not affect the resultant physical density of the delineated 
volume. Despite increased magnitude of motion, the physical density of the moving target did not 





, which is close to the expected 1.0 g/cm
3
 seen on the static image delineated target volume. 
The density of the bone, lung, and soft tissue also remained the same despite the change in 
magnitude of motion, as seen in Table 3.3. They do not move significantly during respiration, and 
the results shown are as expected. 
 
The density calculated for the moving target based on the AIP image showed less accurate results. 
Due to the way the CT numbers are averaged across the motion of the target, an increase in the 
magnitude of motion also resulted in more lung volume being averaged for the final average CT 
number, resulting in lower CT numbers with increasing target motion. This also resulted in a lower 
density value, which is not comparable to the baseline of 1 g/cm
3 
as provided by the static image. 
 
As addressed earlier, plans starting with “CIRS Motion.. ” were taken at a different time with plans 
starting with “BCRPM..”. There was a change in the properties of the CT scanner between the 
different acquisition times. To accommodate for this change, a new CT number to density table was 




Motion..” plans, and the “BCRPM..” plans, as they both used different calibration tables. However, 
corrections have been made to accommodate for this difference, and applying the appropriate CT-
density conversion for the dataset accordingly, meaningful comparison of densities can still be made. 
As seen in the comparison for the CT number for the different reconstructed images and the density 
values in Table 3.2, the CT numbers acquired for the two different sets of images are quite different, 
but the corresponding density values, after applying the appropriate conversion, showed comparable 
results. 
 
Different reconstruction methods revealed different CT numbers for the moving target volume. 
However, apart from results obtained based on AIP image, the physical density of the target remains 
unchanged, despite increasing the magnitude of motion. The increased range of motion results in 
more lung volume being averaged together with the tumour volume during image reconstruction for 
the AIP image, resulting in the lower CT number, and corresponding density. This implies that the 
AIP image may be less suitable and reliable to obtain the CT number for dose calculation purposes. 
The CT numbers based on the reconstructed images tend to fluctuate quite significantly. However, 
once these numbers were converted into density values on the MIP and free breathing image, they 
showed comparable results to the static image. This indicated that the MIP and free breathing image 
was suitable to use for representing the tumour volume. The MIP image shows the extent of motion 
of the tumour volume, while the free breathing image represents the location, shape and size of the 
target volume at approximately midway of the target motion. An accurate representation of the 
tumour volume is important in the treatment planning process. However, a more crucial factor to 
consider in the treatment planning process is if the dose delivered, is accurately represented based on 
the reconstructed images. This will be explored in the next two following chapters of this thesis. 
 
 
The CT datasets images and comparisons were taken for a phantom, with amplitude of motion that is 
constant and regular. The spherical tumour volume in the phantom was 3cm in diameter, moving 
periodically with respiratory motion to simulate a stage I NSCLC lung tumour. In the phantom, 
OARs are also stationary, with only the tumour moving as programmed. While the CIRS phantom 






 In a clinical setting, patients will have irregular respiratory patterns with tumour volumes of varying 
sizes and shapes. Additionally, the study was only taken for motion of up to 40mm. Increased 
tumour motion may cause image artifacts, which will likely result in inaccuracies of the physical 
density values.  In a study by Oechsner et al. [71], they found that tumour location has a significant 
impact on the dose to the lungs. Additionally, OAR dose based on the MIP image set was found to 
be lower compared to the other image datasets. They thus determined that MIP images are less 
suitable for OAR dose assessment.   
 
Another factor is also the baseline drift in the breathing signal, where the breathing trace may shift 
slightly, resulting in a shift in regular periodic breathing motion. The breathing trace is based on the 
external respiratory signal as obtained by the infrared camera and the marker box. If the baseline 
drift is large enough, this could result in reduced dose conformity, especially during longer treatment 
periods. In a study by Seishin Takao et al. [72], that investigated the baseline shifts/drifts of lung 
tumour in SBRT, they found that real time tracking, and careful adjustments of couch or treatment 
margins are necessary to ensure that no underdosage occurs. This is especially important with the 
methods of using AIP and MIP images sets as they are based on acquired 4DCT image sets. 
Therefore, when treating patients using AIP or MIP datasets in treatment planning, motion 
management and proper margins are very important such that conformal dose is delivered to the 
tumour, and minimal dose is delivered to the OARs on a real patient. 
 
The results obtained here are of a simplified phantom, and a clinical patient would provide a less 
predictable and periodic pattern of motion. However, the results do serve as a guide to provide 
incremental confidence when applying MIP and AIP methods. The dose delivery and dose 
distribution based on MIP and AIP datasets will be explored in the proceeding chapters. 
3.7 Conclusion 
 
Contouring the tumour volume on each phase of 4DCT image set can be quite time consuming. 
Instead, treatment planning on different reconstructed images based on a single dataset derived from 




the moving target was quite different for MIP, AIP and the free breathing image respectively. 
However, upon conversion to physical density, the MIP and free breathing image showed similar 




 for the moving target volume. This is comparable to 
the expected 1.0g/cm
3
 expected as seen on the static image. This holds true, where the physical 
density does not change much despite the changing period and magnitude of motion.  
 
The CT number based on the AIP image however showed much lower CT numbers and 
corresponding density values in comparison. Additionally, with increasing motion, the density of the 
target volume also decreased. Due to the way the image is reconstructed, as magnitude of motion is 
increased, more lung volume is being averaged together as well, resulting in the lower average CT 




. However, the delineated 
volume does represent the average density of the tumour volume as it moves throughout the 
respiratory cycle.  
 
Despite an increase in the magnitude of motion, the physical density of the moving tumour volume 
and stationary organs like the bones, soft tissue, and lung do not change. The MIP image shows the 
full extent of motion of the moving tumour, while the free breathing image shows the tumour at 
approximately midway between the two extremes of the tumour motion. Based on the physical 
densities, the MIP and free breathing image dataset could suitably represent the tumour volume. 
While the AIP image does not accurately reflect the physical density of the tumour volume for 
treatment planning, it does however reflect the average position of the tumour as it moves 
throughout the breathing cycle. A more important factor to consider is if using the reconstructed 
images for dose calculation and dose delivery would be suitable. Treatment planning is necessary 
such that careful and conformal dose delivery can be administered to the patient. As such, in the 
proceeding chapters, point dose to the target volume, and the dose distribution to the target volume 






4. Dose Delivery Accuracy 
4.1 Introduction 
 
The aim of radiation therapy is to eliminate the cancer cells within the patient. This is done by 
delivering doses of ionizing radiation to the patient to damage the DNA of the tumour cells. A 
typical delivery method involves using a linear accelerator (linac) to deliver a beam of radiation that 
can be shaped using multi-leaf collimators and wedges, to ensure conformal radiotherapy is 
delivered to the patient. This ensures that radiation is delivered to the tumour cells, while healthy 
normal tissues are spared. Dose delivery accuracy is especially important for SABR, where highly 
conformal radiation dose is being delivered to the tumour volume, in fewer fractions than 
conventional radiotherapy procedures. Additionally, respiratory motion also makes this process more 
complicated as it is important to avoid any nearby organs at risk (OAR). 
 
Treatment planning is an essential part of accurate dose delivery. On treatment planning systems, 
images are studied, and regions of interest (ROI)s and OARs are contoured. Planning and simulation 
enables users to first delineate and identify all the important structures and volumes on the acquired 
CT image. On the treatment planning system, the radiation beam can be shaped accordingly to 
simulate treatment based on the CT image. Dose calculation algorithms can then be used to 
determine the amount of dose delivered to the various volumes of interest, based on a prescribed 
dose as determined by the user. The simulation allows users to better observe the dose distribution to 
the patient first, before delivering radiation treatment to the patient. 
 
Dose Calculation is necessary to account for all the different physical processes that occur between 
the productions of the radiation beam, to how it interacts with the different structures in the body all 
the way to the target volume. In an ideal situation, the calculated dose from the treatment planning 
system would be the same as the delivered patient dose. However, inevitable deviations exist. This 




algorithm used, variations in beam delivery, imperfect modelling, patient changes, and input data 
imperfections [73]. 
 
 In this study, because dose is being delivered to a moving target in the lungs, a factor to consider is 
how the photons from the beam interact as it travels through the different medium, to the tumour 
volume. The lungs are low density, air filled cavities that contain many tiny alveolar air spaces. 
During respiration, this structure expands with inhalation, and contracts with exhalation, changing its 
composition and thus the density throughout respiration. Due to the presence of the changing air-
filled cavities, the lung structure is inhomogeneous. SABR treatment involves the delivery of very 
high energy beams, to a small tumour within the low density lungs. In this low-density structure, 
attenuation of photons become reduced, leading to greater photon fluence, where secondary 
electrons have a greater range, which leads to a phenomenon known as lateral electronic 
disequilibrium (LED), which can cause a reduction in the absorbed dose to both the lungs and the 
target. 
 
Electron disequilibrium can exist in both lateral and longitudinal directions from the central axis of 
the radiation beam. With shallow beam depths, longitudinal electron disequilibrium exists because 
the range of the longitudinal secondary electron is simply greater. This is evident in dose build-up 
regions, where the dose increases before decreasing exponentially [74].  As the photons travel deeper 
in depths or longer distances, attenuation causes fewer photons to travel as the depth increases. This 
means that the charged particle (electron) energy increases with depth, until it approaches the 
maximum longitudinal range of the secondary electrons, where it runs out of energy [74].  
 
Lateral electron disequilibrium (LED) occurs when the lateral range of electron is larger than the 
radius of the beam. This effect causes electrons from the central axis of the beam to be scattered, 
resulting in lowered dose along the central axis of the beam. Electrons at the central axis of the beam 
scatters beyond the field’s edge, and is not replaced, resulting in lowered dose. The effect of this is 
that the dose in the regions can be lower than expected since a dose void occurs [74]. As the energy 
of the radiation beam is increased, the effects of LED would become more obvious. More kinetic 




before depositing its energy, which could result in reduced dose deposition to the central tumour site 
despite increased beam energy. 
 
Dose calculation algorithms used therefore must account for this issue and correct for it such that the 
calculated dose during treatment planning is in agreement with absorbed dose. On Pinnacle
3
, the 
treatment planning system used in this study, the dose calculation algorithm used is called the 
Adaptive Collapsed Cone Convolution Superposition algorithm. This is a model based calculation 
algorithm, introduced by Ahnesjo [75], that accounts for the primary photon fluence of the radiation 
beam, the projection of the primary photon fluence as it travels through the medium to form a 
TERMA (Total Energy Released per Unit Mass) volume, a superposition of the TERMA with dose 
kernels to account for tissue heterogeneities on lateral scatter and an electron contamination factor 
added after photon dose is computed [76]. This algorithm calculates the primary radiation and the 
scatter radiation components, and then superimposes it to produce a final dose distribution to the 
affected volume. 
 
A two-dimensional array is used to describe the energy fluence of the radiation beam as it exits the 
linac head. The incident energy fluence is then projected through the CT image of the patient and 
attenuated using mass attenuation coefficients through ray tracing techniques to form the TERMA 
volume. The coefficients are stored in 3-D lookup tables. To account for changing photon energy at 
various locations, the mass attenuation lookup table is produced using a weighted sum of several 
mono-energetic tables. At each voxel the TERMA is computed using the attenuated energy fluence 
along the ray path and mass attenuation coefficient at that density, depth and off-axis angle [76]. The 
3-Dimensional dose distribution to the patient is computed by superposition of the TERMA volume 
with the energy deposition kernel. The energy deposition kernel represents the spread of energy from 
the initial site, throughout the associated volume [76]. With the adaptive convolution superposition 
algorithm, at regions where there was higher heterogeneity, the dose was actively computed whereas 
at regions were there was more homogeneity, the system interpolated the dose. This helps to reduce 
computation time. While Monte Carlo simulation is still considered to be the gold standard for dose 
calculation, especially in heterogeneous medium, convolution superposition methods are still a 







, using a dose calculation algorithm, the dose to the target volume can be 
determined. As mentioned in previous chapters, to accommodate for the issue of motion and 
reducing workload, various image reconstruction methods like using a specific phase from the 4DCT 
dataset, MIP or AIP images are used to observe the tumour volume as it moves in the lung. Despite 
being obtained from the same 4DCT dataset, the resultant delineated volume on the reconstructed 
image will look very different. As seen in Chapter 3 regarding CT number consistency, the CT 
numbers are different based on the different reconstructed images. Additionally, on the AIP image, 
as magnitude of motion increased, the CT number fluctuated significantly, resulting in different 
calculated physical density for the moving target volume. However, on the free breathing image and 
the MIP image, despite slight fluctuations in the CT number, the resultant physical density of a 
moving target remained the same and comparable to when the target is stationary. It is important that 
the tumour volume is accurately represented to ensure dose conformality during treatment planning, 
and thus accurate dose delivery as well. 
 
Dose calculation is dependent on the CT number. The CT numbers can be converted to density 
values and electron density values of the tissue being imaged, which is necessary for scaling of the 
energy deposition kernels [77] used for dose calculation purposes. Even though the CT number and 
corresponding density based on the AIP image fluctuated more significantly, it also represents the 
average position of the tumour motion. A more meaningful study would be to assess the dose 
calculation and dose delivery based on the different types of reconstructed images. In this chapter, 
the accuracy of Pinnacle dose as calculated on each dataset will be assessed in comparison to dose 
measured on the CIRS phantom on the LINAC under the same conditions. 
 
4.2 Aim 
The main aim in this chapter is to determine the accuracy of dose calculation to a point on different 
reconstructed 4DCT image types with varying CT numbers, mainly the Maximum Intensity 
Projection (MIP) image, the Average Intensity Projection (AIP) image, and the free breathing 
image. The purpose is to see how well the various reconstructed image compare to one another for 
the dose calculation of a moving tumour within the low-density lungs. As seen in the preceding 




but with increasing magnitude of motion as well. Thus, it would be interesting to see how this affects 
the calculated dose, and how well it will compare to measured dose under the same conditions. In 
this chapter, we compare the dose delivered to a point within the target volume as seen on the 
various 4DCT reconstructed image on the treatment planning system, in comparison to the measured 




In the previous chapter, the moving target was delineated on the reconstructed images of the 4DCT 
dataset, on the MIP, AIP and free breathing image. The images were delineated using the auto-
contour option on Pinnacle
3
 treatment planning system. The auto-contour option was set to a lower 
threshold of 800 and an upper threshold of 4096. Even though the auto–contour option was used to 
delineate the volumes, the images were also manually checked to ensure that the moving target was 
properly delineated on all of the reconstructed images. In all the plans, a moving target of 3cm in 
diameter was used to represent a stage I small non – small lung cancer (NSCLC). The target was set 
to move in the CIRS lung phantom with varying magnitudes of motion and at different periods. In 
this chapter, the same sets of images used in chapter 3 were used to determine the point dose 
measurements.  
 
This study involved comparing the calculated Pinnacle
3
 point dose in comparison to the measured 
point dose on the CIRS phantom from the Linac. To do this, the pinnacle
3
 point dose was determined 
first. The moving target volume was first determined and delineated on the MIP dataset. A single 
anterior field was added with an MLC aperture conformed to the target volume with a 5mm margin 
as seen in Figure 4.1. Point dose was calculated for a delivery of 200MU. Once this was determined, 
the MIP plan was copied onto both the AIP and Free Breathing dataset using the dynamic planning 
tool available on Pinnacle
3
. For all three MIP, AIP and free breathing datasets, the point dose to the 





Figure 4.1 Single anterior field with MLC aperture with 5mm margin conformed to the target volume, parallel to the target motion 
 
For all the combinations of period and magnitude of motion, as seen in Table 3.1, the point dose to 
the MIP, AIP and free breathing dataset was calculated, with the target volume delineated based on 
the MIP image. The plans were generated for both 6MV and 10MV photons. On all the plans, a 3 x 3 
x 3 mm dose grid with adaptive collapsed cone convolution algorithm was used for dose calculation. 




 point dose was determined, the point dose to the CIRS phantom from the Linac 
was determined next. Using the treatment plans from Pinnacle
3
, the same settings were applied to the 
Linac, to deliver 200MU to the CIRS phantom, at 6MV and 10MV. The MLCs on the Linac helped 
to shape a conformal beam onto the phantom, similar to that simulated on Pinnacle
3
. The target 
within the CIRS phantom was also set to move according to the different combinations of period and 
magnitude of motion as seen in Table 3.1, and irradiated by the Linac with the same settings set on 




measure the point dose by the Linac each time the phantom was irradiated. Measurements were then 
converted to dose values in cGy, for comparison with the point dose values obtained from Pinnacle
3
. 




In the following graphs shown in Figure 4.2,Figure 4.3,Figure 4.4, and Figure 4.5, the graphs show 
the point dose values on the reconstructed images, for both calculated Pinnacle point dose, and the 
measured point dose. The accompanying tables seen in Table 4.1, Table 4.2, Table 4.3 and Table 
4.4, show the point dose values.  
 
Results labelled starting with “Pinnacle..” are the treatment planning system calculated dose, while 






Figure 4.2 point dose comparison for 6MV beam with target moving at 10mm, 20mm, 30mm and 40mm in the SI direction only. 
Table 4.1 point dose values with 6MV beam, with target volume moving at varying amplitudes for different reconstructed image, 
moving in the SI direction only 
6MV beam with SI motion only 
Amplitude 10mm 20mm 30mm 40mm 
Pinnacle MIP(3 secs) 171.2 172.7 172.9 - 
Pinnacle MIP(5 secs) 171.2 173.0 167.8 174.1 
Pinnacle MIP(10 secs) 171.6 173.4 168.2 175.8 
  
Pinnacle AIP(3 secs) 172.0 174.0 173.7 - 
Pinnacle AIP(5 secs) 171.2 173.8 169.8 173.4 
Pinnacle AIP(10 secs) 172.2 174.4 170.6 176.1 
  
Pinnacle Free Breathing(3 secs) 171.9 173.5 173.7 - 
Pinnacle Free Breathing(5 secs) 170.2 172.8 170.3 175.0 
Pinnacle Free Breathing(10 secs) 171.7 173.7 168.1 176.8 
  
Linac static(3 secs) 176.2 177.7 177.8 - 
Linac static(5 secs) 176.1 177.7 178.9 179.7 





Linac moving(3 secs) 176.4 178.0 178.1 - 
Linac moving(5 secs) 176.4 178.0 179.3 180.3 
Linac moving(10 secs) 176.4 178.1 177.5 180.0 
 
 
Most of the plans showed similar readings when moving at the same amplitude of motion, and at 
different periods as seen in the Table 4.1. Only motion at 30mm showed larger differences between 
the values at different periods of motion. The measured Linac point dose values fluctuated very little 
despite the change in the period of motion. 
 
Figure 4.3 point dose comparison for 6MV beam with target moving at 10mm, 20mm, 30mm and 40mm in the SI direction, and 10mm 
in the AP direction for the measured and calculated doses 
Table 4.2 point dose values with 6MV beam, with target volume moving at varying amplitudes for different reconstructed image, 
moving in the SI direction, with 10mm AP motion 
6MV beam with 10mm AP motion and SI motion 
Amplitude 10mm 20mm 30mm 40mm 
Pinnacle MIP(3 secs) 163.4 166.1 167.6 - 
Pinnacle MIP(5 secs) 163.2 165.6 168.2 169.7 





Pinnacle AIP(3 secs) 166.5 168.5 170.2 - 
Pinnacle AIP(5 secs) 166.7 168.7 170.2 171.1 
Pinnacle AIP(10 secs) 166.5 168.8 170.2 171.0 
  
Pinnacle Free Breathing(3 secs) 166.7 168.6 169.3 - 
Pinnacle Free Breathing(5 secs) 166.6 168.0 169.4 170.7 
Pinnacle Free Breathing(10 secs) 166.2 165.4 168.4 170.2 
  
Linac static(3 secs) 173.9 175.7 176.9 - 
Linac static(5 secs) 173.8 175.5 176.9 178.1 
Linac static(10 secs) 173.7 175.5 176.8 177.9 
  
Linac moving(3 secs) 174.0 176.0 177.3 - 
Linac moving(5 secs) 174.0 175.9 177.2 178.7 
Linac moving(10 secs) 173.9 175.8 177.3 178.4 
 
With added AP motion of 10mm, both measured and calculated point dose values are found to be 
lower compared to the case of only SI motion. However as seen in Figure 4.3 and Table 4.2, even 






Figure 4.4 point dose comparison for 10MV beam with target moving at 10mm, 20mm, 30mm and 40mm in the SI direction only for 
the measured and calculated doses 
Table 4.3 point dose values with 10MV beam, with target volume moving at varying amplitudes for different reconstructed image, 
moving in the SI direction only. 
10MV beam with SI motion only. 
amplitude 10mm 20mm 30mm 40mm 
Pinnacle MIP(3 secs) 179.9 182.4 182.9 - 
Pinnacle MIP(5 secs) 180.0 182.5 179.6 182.2 
Pinnacle MIP(10 secs) 180.3 182.9 180.3 185.6 
  
Pinnacle AIP(3 secs) 178.6 180.4 178.4 - 
Pinnacle AIP(5 secs) 173.1 176.8 175.0 177.8 
Pinnacle AIP(10 secs) 176.6 181.4 177.2 177.9 
  
Pinnacle Free Breathing(3 secs) 178.7 181.1 181.3 - 
Pinnacle Free Breathing(5 secs) 170.3 177.5 177.3 179.9 
Pinnacle Free Breathing(10 secs) 175.5 181.4 179.5 183.5 
  
Linac static(3 secs) 184.7 186.8 187.1 - 
Linac static(5 secs) 184.7 186.8 188.5 189.7 





Linac moving(3 secs) 184.6 186.6 186.5 - 
Linac moving(5 secs) 184.6 186.7 188.3 189.6 
Linac moving(10 secs) 184.7 186.9 187.9 189.4 
 
At 10MV, the measured and calculated point dose values showed higher values compared to 6MV as 
seen in Table 4.3. Calculated point dose values at 10MV with just SI motion at different period, on 
the same reconstructed image type, showed slightly more fluctuations as seen in Figure 4.4. 
However, except for the difference between the calculated point dose values on the free breathing 
image at different periods at 10mm, the dose difference remained under 5cGy.  
 
 
Figure 4.5 point dose comparison for 10MV beam with target moving at 10mm, 20mm, 30mm and 40mm in the SI direction, and 
10mm in the AP direction for the measured and calculated doses 
Table 4.4 point dose values with 10MV beam, with target volume moving at varying amplitudes for different reconstructed image, 
moving in the SI direction, with 10mm AP motion 
10MV beam with 10mm AP motion and SI motion 
Amplitude 10mm 20mm 30mm 40mm 




Pinnacle MIP(5 secs) 175.4 178.0 180.2 181.7 
Pinnacle MIP(10 secs) 175.4 178.2 180.2 181.6 
  
Pinnacle AIP(3 secs) 175.0 177.1 177.7 - 
Pinnacle AIP(5 secs) 174.5 176.5 177.0 177.0 
Pinnacle AIP(10 secs) 174.5 176.3 177.0 176.9 
  
Pinnacle Free Breathing(3 secs) 174.9 177.4 178.8 - 
Pinnacle Free Breathing(5 secs) 174.7 177.6 179.5 180.7 
Pinnacle Free Breathing(10 secs) 175.3 172.0 180.0 180.9 
  
Linac static(3 secs) 183.6 186.0 187.6 - 
Linac static(5 secs) 183.2 185.7 187.5 188.9 
Linac static(10 secs) 183.1 185.6 187.4 188.7 
  
Linac moving(3 secs) 183.5 185.6 187.3 - 
Linac moving(5 secs) 183.0 185.4 187.2 188.9 
Linac moving(10 secs) 182.9 185.3 187.2 188.6 
 
The measured and calculated point dose values with 10mm AP motion is lower compared to when 
AP motion is absent. Based on Table 4.4 and Figure 4.5, changing the period did not significantly 
affect the calculated or measured point dose values. The difference between the calculated point 
dose values for MIP, AIP and free breathing was also not significantly different at the same 
amplitude. 
 
The dose measured was the Linac dose, while the calculated dose on the treatment planning has been 
referred to as the Pinnacle
3
 dose. On Pinnacle
3
, point dose was calculated for plans with a 3cm target 
volume, moving in combination of varying amplitudes and periods of motion. The target moves in 
the SI direction varying from 10mm (±5mm), 20mm (±10mm), 30mm (±15mm) and the greatest 
amplitude being 40mm (±20mm). AP motion was left at either 0mm or changed to 10mm(±5mm) in 
amplitude. These measurements were taken at different periods as well (3 seconds, 5 second and 10 
second periods). On all plans for both measured and calculated dose, 200 MU of radiation was 
delivered to the target volume. 
 
For most of the plans, for both measured Linac point dose and calculated Pinnacle
3
 point dose, the 




dose of the tumour volume on the MIP image at 10mm, for periods of 3 s, 5s, and 10s was 
171.2cGy, 171.2cGy, and 171.6cGy respectively. Similarly, the measured Linac point dose at the 
same amplitude, was similar despite changing the period of motion. Thus, for both measured and 
calculated point dose values, the dose at the same amplitude, but with varying period was averaged 
to provide the graphs seen in Figure 4.6,Figure 4.7,Figure 4.8, and Figure 4.9. This was done so 
that the difference between the calculated point dose for MIP, AIP and Free breathing, could be 
compared to the measured point dose values at different amplitudes. 
 
 
Figure 4.6 Comparison of the average point dose for different reconstructed images at different amplitudes for both Pinnacle3 and 
Linac with only varying SI motion, with a 6MV beam. 
Table 4.5: Averaged point dose at 6MV with only SI motion only at different amplitudes and image types. 
6MV SI motion only 
Average Dose(cGy) 10mm 20mm 30mm 40mm 
Pinnacle MIP(average) 171.3 173.0 169.6 175.0 
Pinnacle AIP(average) 171.8 174.1 171.4 174.8 
Pinnacle Free Breathing(average) 171.3 173.3 170.7 175.9 
Linac static(average) 176.2 177.7 177.9 179.7 
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Figure 4.7 Comparison of the average point dose for different reconstructed images at different amplitudes for both Pinnacle and 
Linac, with AP motion of 10mm, and varying SI motion with a 6MV beam. 
Table 4.6: Averaged point dose at 6MV with only SI motion and AP motion of 10mm at different amplitudes and image types. 
6MV SI and AP motion 
Average Dose(cGy) 10mm 20mm 30mm 40mm 
Pinnacle MIP(average) 163.2 165.9 168.0 169.6 
Pinnacle AIP(average) 166.6 168.7 170.2 171.1 
Pinnacle Free Breathing(average) 166.5 167.3 169.0 170.5 
Linac static(average) 173.8 175.6 176.9 178.0 
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Figure 4.8 Comparison of the average point dose for different reconstructed images at different amplitudes for both Pinnacle and 
Linac with only varying SI motion, with a 10MV beam. 
Table 4.7: Averaged point dose at 10MV with only SI motion only at different amplitudes and image types. 
10MV SI motion only 
Average Dose(cGy) 10mm 20mm 30mm 40mm 
Pinnacle MIP(average) 180.1 182.6 180.9 183.9 
Pinnacle AIP(average) 176.1 179.5 176.9 177.9 
Pinnacle Free Breathing(average) 174.8 180.0 179.4 181.7 
Linac static(average) 184.8 186.9 187.9 189.5 









10mm(cGy) 20mm(cGy) 30mm(cGy) 40mm(cGy)
10MV average dose comparison for different image types 











Figure 4.9 Comparison of the average point dose for different reconstructed images at different amplitudes for both Pinnacle and 
Linac, with AP motion of 10mm, and varying SI motion with a 10MV beam. 
Table 4.8: Averaged point dose at 10MV with only SI motion and AP motion at different amplitudes and image types. 
10MV average dose comparison SI and AP motion 
Average Dose(cGy) 10mm 20mm 30mm 40mm 
Pinnacle MIP(average) 175.4 178.1 180.1 181.7 
Pinnacle AIP(average) 174.7 176.6 177.2 177.0 
Pinnacle Free Breathing(average) 175.0 175.7 179.4 180.8 
Linac static(average) 183.3 185.8 187.5 188.8 
Linac moving(average) 183.2 185.4 187.2 188.8 
 
 
Based on the results obtained, for both calculated Pinnacle
3
 point dose and measured Linac dose at 
both 6MV and 10MV, as the amplitude of the superior/inferior SI motion increased from 10mm, to 
40mm, the point dose increased as well. Interestingly, the point dose was found to be lower when 
anterior/posterior AP motion is introduced, for both the calculated Pinnacle
3
 point dose and 
measured Linac dose. In all the plans, 200 MU of radiation is delivered to the target volume moving 
within the CIRS lung phantom. In all cases, the measured point dose delivered by the Linac was 
found to be greater than the calculated Pinnacle
3 







10mm(cGy) 20mm(cGy) 30mm(cGy) 40mm(cGy)










dose values from Pinnacle
3 
was underestimated. The discrepancy between the measured and the 
planned dose values were greater for with the 10MV beam results. 
 
At beam energy of 6MV, based on the calculated Pinnacle
3
 point dose values, there is not a 
significant difference between the point dose calculated on the different reconstructed images of 
MIP, AIP or the free breathing image as seen in Table 4.5 and Table 4.6. However, most of the plans 
showed that the calculated Pinnacle
3
 point dose on the AIP image was highest in comparison to the 
MIP and the free breathing image as seen in Figure 4.6 and Figure 4.7. The MIP image also showed 
the lowest calculated point dose with a 6 MV beam delivering 200MU of radiation. In contrast to 
this, at beam energy of 10MV, calculated point dose on the MIP image showed the highest 
calculated point dose compared to calculated dose on the AIP and free breathing image as seen in 
Figure 4.8 and Figure 4.9 while most plans also showed dose calculation on the AIP image 
generated the lowest point dose values. Table 4.7 and Table 4.8 both show the calculated and 
measured Pinnacle
3
 dose values when 200MU is delivered with a 10MV beam. 
 
Percentage(%) dose difference was used to observe the difference between the calculated point dose 
on Pinnacle, in comparison to the measured dose obtained from the ionization chamber reading. 
Here, the percentage difference was considered for the calculated Pinnacle
3
 point dose on the AIP, 
MIP and free breathing dataset, in comparison to the with the measured Linac point dose on the 






Figure 4.10: 6MV averaged % dose difference with SI motion only comparison at different amplitudes for measured and calculated point dose 
Table 4.9: Averaged % dose difference at 6MV with only SI motion only at different amplitudes and image types. 
6MV SI motion only average % dose difference 
Average % dose difference 10mm 20mm 30mm 40mm 
MIP(average) (%) 2.9 2.8 4.9 2.9 
AIP(average) (%) 2.6 2.2 3.9 3.0 
Free Breathing(average) (%) 2.9 2.7 4.3 2.4 
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Figure 4.11: 6MV averaged % dose difference with SI motion and AP motion comparison at different amplitudes for measured and calculated point 
dose 
Table 4.10: Averaged % dose difference at 6MV with only SI motion and AP motion at different amplitudes and image types. 
6MV SI and AP motion only average % dose difference 
Average % dose difference 10mm 20mm 30mm 40mm 
MIP(average) (%) 6.2 5.7 5.2 5.0 
AIP(average) (%) 4.2 4.1 4.0 4.2 
Free Breathing(average) (%) 4.3 4.9 4.7 4.5 
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Figure 4.12 10MV averaged % dose difference with SI motion only comparison at different amplitudes for measured and calculated point dose. 
 
Table 4.11: Averaged % dose difference at 10MV with only SI motion only at different amplitudes and image types. 
10MV SI motion only average % dose difference  
Average % dose difference 10mm 20mm 30mm 40mm 
MIP(average) (%) 2.5 2.2 3.5 3.0 
AIP(average) (%) 4.6 3.9 5.7 6.2 
Free Breathing(average) (%) 5.3 3.6 4.4 4.1 
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Figure 4.13 : 10MV averaged % dose difference with SI motion and AP motion of 10mm comparison at different amplitudes for measured and 
calculated point dose 
Table 4.12: Averaged % dose difference at 10MV with only SI motion and AP motion at different amplitudes and image types. 
10MV SI and AP motion only average % dose difference 
Average % dose difference 10mm 20mm 30mm 40mm 
MIP(average) (%) 4.2 3.9 3.8 3.8 
AIP(average) (%) 4.6 4.8 5.3 6.3 
Free Breathing(average) (%) 4.5 5.3 4.2 4.2 
static(average) (%) -0.1 -0.2 -0.2 0.0 
 
 
The % dose different graphs, Figure 4.10, Figure 4.11, Figure 4.12 and Figure 4.13 and 
corresponding tables, Table 4.9, Table 4.10, Table 4.11 and Table 4.12, show that the measured 
Linac dose was consistently higher than the calculated Pinnacle
3
 point dose on the AIP, MIP and 
free breathing image dataset. Comparison was made with the measured doses, of when the phantom 
was static simulating breath hold situations. The difference between the two measured point dose 
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At 6MV, the % dose difference for MIP was the greatest in most plans, even as the amplitude is 
increased as seen in Figure 4.10 and Figure 4.11, while % dose difference for AIP is the least. The 
% dose difference also increased when AP motion is added to the plans. At 6MV, the maximum % 
dose difference did not exceed 6.2% as seen in Table 4.9 and Table 4.10. The difference between the 
% dose difference for the measured point dose between static and moving, which simulates breath 
hold and the free breathing respectively, shows minor difference, not exceeding 0.3%, for 6MV and 
10MV.  
 
At 10MV, AIP image shows the greatest % dose difference for most of the plans while the % dose 
difference for MIP is the lowest in most cases. This was at 6.3% and 4.2% for AIP and MIP 
respectively. The % dose difference also increases as AP motion is added to the plans as seen in 
Table 4.12, with lower % dose differences recorded without AP motion as seen in Table 4.11. The 
10MV plans showed greater discrepancy between the measured and calculated point doses, as seen 
in the greater % dose difference values for the 10MV plans. 
 
To summarize, based on the results obtained, the measured Linac point dose on the phantom was 
consistently greater than the calculated Pinnacle
3
 dose, regardless of the beam energy, period, or 
magnitude of motion. This is evident in the positive % dose differences comparison between the 
calculated Pinnacle dose with the measured Linac point dose. The dose difference shows that dose 
calculation by Pinnacle
3
 underestimates the point dose to the target volume. At 10MV, the difference 
between the measured Linac dose and the calculated Pinnacle
3
 dose increases. The maximum 
recorded dose % dose difference was 4.2%, 6.3% and 5.3% for MIP, AIP and free breathing 
respectively. At 6MV however, the maximum difference was at 6.2%, 4.2% and 4.9% for MIP, AIP 
and free breathing respectively. Additional point dose comparison graphs are shown in Appendix A 
(part A2A.2 Point Dose comparisons for Chapter 4). 
 
 As the amplitude of motion increased, so did the calculated and measured point doses to the 3cm 
tumour volume. On pinnacle
3
, even though the reconstructed CT image datasets had different CT 
numbers, and represented the tumour volume differently, the difference in the calculated dose to the 






point dose on the MIP, AIP and free breathing CT dataset, under the same 







The goal was to determine the accuracy of the calculated point dose on the AIP, MIP and free 
breathing CT dataset, in comparison to the measured point dose under the same motion settings, to a 
3cm moving tumour volume within the lungs. Since the 3 different datasets represent the tumour 
volume differently, the goal was also to determine which of the reconstructed dataset was best to use 
for dose calculation purposes.  
 
From the results, the calculated Pinnacle
3
 point dose was underestimated on all the reconstructed CT 
datasets, compared to the measured Linac point dose. There could be multiple factors that could 
have contributed to this discrepancy. One of the reasons could be the interplay effect, where the 
relative motion between the MLC leaves of the Linac and the point the dose is measured can lead to 
dosimetric effects, resulting in the higher measured dose. On the treatment planning system, the dose 
calculation is dependent on multiple factors, such as the beam energy, the field size, the field 
positioning, and the dose calculation algorithm itself. As the beam travels to the small 3cm diameter 
moving target volume, it travels through varying densities, from the lower density lung region, into 
the higher density target volume. Since it is a relatively small volume, point dose calculation may be 
taken close to or within the buildup region, where dose may be lower. Additionally, because the re-
entrant beam enters the small target volume from a region of higher density, to a region of lower 
density, the density variation could result in electron scattering, and thus lateral electron 
disequilibrium, resulting in a lower calculated point dose. This situation is further complicated since 
the target volume is moving at different amplitudes in the various plans. The relationship between 
the planned and measured dose will change depending on the tumour volume, the field size, and the 






MIP image is chosen for target delineation because it sufficiently shows the extent of motion of the 
target. In literature, there have been multiple studies [27], [58], [60], [62], that have suggested that 
MIP image is suitable for small tumours in the early stages  that are not attached to or intersect any 
part of the lung walls. According to Bradley et al. [27], MIP images are also considered to be 
superior in defining the internal target volume ITV. Compared to the other reconstructed images, 
target delineation on the MIP image also provides sufficient volume to accommodate for lateral 
electron scatter caused by moving through varying densities to reach the target volume.  
 
 In this study, the beam energy used were only 6MV and 10MV. As expected, an increase in the 
beam energy showed increased measured and calculated point dose values. The advantage of using 
the higher energy beam was that it provided deeper penetration, and greater dose uniformity. This is 
because at higher energies, the electrons have a greater electron range, where the more energetic 
electrons are able to travel further before being scattered or depositing the dose.  
 
Additionally, the reconstructed images of the MIP, AIP and free breathing CT datasets all represent 
the target volume differently. The reconstructed CT datasets have different CT numbers and 
corresponding density representation. The target volume on the MIP image is represented as a denser 
medium with a higher CT number, while the target volume on the AIP image is represented as a 
lower density medium, with a lower CT number.  
 
The point dose difference between the different reconstructed images under the same condition 
(period and magnitude of motion) was not significant. However, a noticeable difference is that in 
most of the plans, the MIP showed greatest calculated point dose values with a 10MV beam, while at 
6MV, the AIP image showed the greatest calculated point dose values. When a higher 10MV beam 
is used, the lateral range of electrons increased. To ensure electronic equilibrium is achieved, a 
sufficiently large enough volume must be contoured. This study involved using a small 3cm target 
volume, moving within the low-density lungs. It is therefore reasonable that at 10MV, dose 
calculation on the MIP image, which provides a greater scattering volume, also provided the higher 






The results showed that the point dose also increased as the SI motion was increased. Interestingly, 
the dose values were lower when AP motion is introduced. As the amplitude of motion increased, to 
encompass the entire target volume, the field size increased as well. This means that more electrons 
are able to deposit dose to the delineated volume, and thus the calculated dose value increased on 
Pinnacle
3
. Thus, the calculated dose increases, as field size increases by increasing the motion. In 
addition to this, increasing the field size also resulted in less backscatter to the monitor chamber 
within the treatment head of the Linac. Therefore, measured dose increased.  
 
Comparing the dose calculated on the MIP, AIP and free breathing image, while there were some 
variations in the dose values, the dose difference is not significant between the different 
reconstructed CT datasets. Even though each of the reconstructed datasets represented the delineated 
volume differently, with different corresponding CT numbers, the dose difference was not 
significant. The variation between the calculated point dose on MIP, AIP and free breathing was 
smaller. Most plans on Pinnacle for the MIP, AIP and free breathing images showed a dose 
difference of less than 5 % in difference. This is within the clinically acceptable limit for dose 
accuracy according the ICRU Report no. 24 [78]. 
 
The purpose of this chapter was to compare between the calculated pinnacle dose, and the measured 
dose. Then comparisons were made for the calculated pinnacle dose on the different types of 
reconstructed images, to determine if any one specific 4DCT images were suitable for dose 
calculations. Based on the results of the planned pinnacle dose between the different reconstructed 
4DCT datasets, there is not a clinically significant difference between the calculated point dose 
values. Dose calculation of a small moving tumour, within the low-density lungs can be quite 
complex and affected by multiple factors as discussed in this section. It is also clear that the 
calculated dose on Pinnacle
3
 is underestimated in all the plans, compared to the measured point dose 
values. There is no clear relationship that suggests that a specific image type was more suitable than 
another for dose calculation. Therefore, it would be erroneous to assume that any one specific image 
type is suitable for treatment planning and dose calculation for the tumour volume, based on the 




it would be better to study the dose distribution to the entire volume, by observing the dose volume 




Dose calculation to a small 3cm moving target within the low-density lung volume can be 
complicated and affected by multiple factors such as beam energy, dose calculation algorithm, field 
size, magnitude of motion, and image type used for dose calculation. Calculated point dose values on 
all the plans are underestimated on the Pinnacle
3
 treatment planning system, compared to the 
measured point dose values. Increasing the beam energy resulted in increased point dose values. 
Increasing the amplitude of motion, and thus the field size of radiation also resulted in an increase in 
both measured and recorded point dose values. However, it is difficult to generalize clearly if a 
specific reconstructed 4DCT dataset is necessarily suitable for dose calculation based on the point 
dose measurements. Dose calculation on the MIP, AIP, and free breathing images for point dose 
under the same conditions, was not significantly different from one another when comparing the 
point dose for a small target volume moving in a low-density region, representing the lung.   
 
Radiation therapy especially SBRT requires highly conformal treatment planning. Evaluation of the 
dose distribution throughout the volume is necessary to determine the validity and quality of the 
















5. Dose Volume Histogram (DVH) 
5.1 Introduction 
 
In the previous chapter, point dose measurements to the target volume were measured and 
calculated. A more accurate and necessary consideration in radiation treatment planning is the dose 
distribution to the entire delineated volume. This can be done by observing the dose volume 
histogram.  
 
Dose Volume histogram is a visualization method used to show the 3D dose distribution to the 
tumour volume or anatomical structure of interest in a 2D graph. It identifies the amount of dose 
delivered to the entire defined or delineated volume of the anatomical structure, presented in the 
form of a graph. It presents a range of how much dose is delivered, corresponding to a specific 
volume. This allows physicians to do a subjective quantitative assessment of the treatment plans, as 
well as comparing the DVHs obtained from multiple treatment plans. The main problem with 
observing DVHs however is the inherent loss of spatial information. When 3D dose distribution is 
condensed into the 2D DVHs, spatial information is lost as a result. 
 
There are two main types of DVHs, the Differential DVH, and the Cumulative DVH. These DVHs 
are usually generated during treatment planning. The Differential DVH is created by grouping the 
frequency of voxels within a dose distribution, into a discreet range of dose values [74]. The 
resultant graph displays the absolute or relative volume within that discreet dose range. The 
Cumulative DVH on the other hand, sums up the frequency of voxel in the dose distribution, and 
groups it as cumulative dose values less than a dose range [74], rather than just discreet range of 
dose values. Cumulative DVHs are more commonly used in the planning process as well compared 
to Differential DVHs. Cumulative DVHs will always start at maximum volume (or 100% volume or 
maximum frequency), while Differential DVHs typically start at minimum volume (0% volume or 






Figure 5.1 this is an example of the differential DVH (left) and cumulative DVH(right) plans obtained during treatment 
planning comparing the DVHs from different image types (MIP, AIP and average summed 8 phases). Note that these 
DVHs have been normalized. 
 
As seen from the image, the DVHs graph is a planning evaluation tool that compares the dose 
distribution to the volume being treated. From the DVH, users can determine if adequate dose, is 
being delivered to the target volume, and hot and cold spots in normal tissues can also be 
determined. As seen in the Cumulative DVH graph, the graph labelled MIP PTV shows the best 
tumour volume coverage. However, it is also necessary to ensure that normal healthy tissues are 
properly protected and not irradiated when choosing the optimum plan for dose delivery.   
 
In observing the DVH, an ideal Differential DVH for treatment would show a sharp well-defined 
peak, with a sharp buildup and a quick fall off. In observing the Cumulative DVH for treatment, the 
ideal curve would start with a relatively flat line at maximum volume, with a sharp, steep fall off 
when maximum dose is delivered to the target volume. This indicates that maximum dosage is being 
delivered to the target volume, with minimum normal tissue volume receiving high doses. With 
respect to observing the cumulative DVH for normal healthy tissues however, ideally it would be 




dosage from the radiation treatment. This is usually easier to achieve if the normal healthy tissue is 
not overlapping or located further away from the target volume. 
 
.During treatment planning, the different contoured regions will display different DVHs. During 
treatment planning on patients, it is important to ensure that while maximal dose is delivered to 
patients, organs at risk (OAR) are spared as well such that no complications arise as a result. DVH 
comparisons between different contoured volumes such as the Gross Tumour Volume (GTV), the 
Planning Target Volume (PTV) will show varying DVHs as well. 
 
Treatment planning based on different image types will also affect the resultant DVHs. The shape 
and volume delineated in different image types like Average Intensity Projection (AIP) images and 
Maximum Intensity Projection (MIP) images can be quite different from one another. There have 
been studies [27, 30, 43, 58, 62] that have indicated MIP images to be suitable for target delineation 
during treatment planning for stage I lung cancers for SABR as the whole range of motion of the 
tumour in the lungs are delineated throughout the respiration cycle. According to Muirhead et al. 
[62], MIP images are both reliable and faster to delineate compared to delineating all phases of the 
image sets obtained from the CT scanning. Some studies have also used AIP images are also used 
for both target delineation and dose calculations. In the study by Khamfongkhruea et al. [42], the 
study performed treatment planning on AIP images, free breathing images and Mid ventilation 
images. They concluded that AIP images were sufficient for both target delineation and dose 
calculation. Another study by Oechsner et al. [79], that investigated and compared treatment 
planning between MIP, AIP and Mid ventilation images, found that AIP images and Mid ventilation 
images were suitable for treatment planning, whereas MIP images were not as reliable for dose 
accuracy.  
 
Treatment planning can also be done on all phases of the 4DCT images. The tumour volume on each 
phase of the respiration cycle can be delineated and the dose to the volume can then be calculated. 
The dose to the tumour volume, at every position at the different phases of the respiratory cycle can 
be determined. According to Zhang et al. [78], A GTV volume was defined at the end expiration 
phase. Contours were then expended to form a clinical target volume (CTV). The same volume is 




deformable image registration algorithm, and defined as the internal clinical target volume (ICTV). 
Dose calculation was done on each individual phase. When compared to treatment planning on MIP 
or AIP image, this method is more time consuming and labour intensive. However, since dose is 
being calculated at each phase throughout the respiratory cycle, it would provide an accurate account 
of the amount of dose delivered, at each time and position throughout the respiratory cycle. 
 
Dose calculations based on these different image types could be considerably different. Since the 
reconstructed image are represented differently, and dose calculation is dependent on the electron 
density, it would be interesting to compare the dose distributions in these volumes to see how the 
different plans provided different dose distributions to the volume. Additionally, it would also be 
interesting to see how these plans hold up as tumour motion increases in amplitude or when 
additional motion is included. In this chapter, the dose volume histogram (DVH) will be used as a 
means of comparing the dose distribution to the volume. 
5.2 Aim 
 
The third and final aim is to observe the dose distribution to the target volume as calculated on the 
different reconstructed images. The dose distribution to the delineated target volume is more 
relevant in the treatment planning process for the treatment of the patient. Additionally, since 4DCT 
is primarily used for imaging tumours involving motion, it is important that dose calculation on the 
reconstructed image is accurate even as the magnitude of motion of the tumour or breathing motion 
is increased. This study involves comparison of the dose distribution to the target volume based on 
treatment planning on the MIP, AIP and free breathing image compared to the 4DCT image set to 
determine the equivalency of the dose as magnitude of motion is increased. 
 
Based on the plans created on Pinnacle
3
, dose volume histograms (DVH) can be constructed for all 
the different image types of MIP, AIP and free breathing for dose distribution comparisons. This can 
be achieved by comparing the DVH graphs obtained for 4DCT, against the DVH graphs obtained for 





The aim is to study the equivalency of treatment planning based on the MIP, AIP, and free breathing 
image, relative to the 4DCT dataset based on the DVH dose distributions graphs. Based on this, it 
would be interesting to see if the equivalency still holds, if the magnitude of motion is increased. 
This is the main reason why 4DCT imaging is used and it is thus imperative that the reconstructed 
images still correctly represent the target volume despite the magnitude of motion. 
 
In this study, comparisons will be made for both differential and cumulative DVHs at 6MV and 
10MV beams on the 3cm moving target volume within the CIRS phantom. The DVH graph dose 
distributions are calculated and produced on Pinnacle
3





In the previous chapters, 4DCT dataset for a moving phantom, the CIRS Dynamic Thorax phantom 
at different amplitude and period has been obtained. The 4DCT dataset was exported onto the 
Pinnacle
3
 treatment planning system, where regions of interest were delineated, and the CT number 
for various volumes were identified. Point dose values to the target volume was also calculated using 
the Pinnacle
3
 treatment planning system dose calculation algorithm. MIP and AIP datasets were 
already reconstructed based on the obtained 4DCT dataset as seen in previous chapters. 
 
In this chapter, the dose to the entire delineated target volume was evaluated by observing the dose 
volume histogram, DVH graphs. On the treatment planning system, only a single beam of radiation 
was used to irradiate the target volume, with the MLC aperture conformed to the target volume with 
a 5mm margin. It should be noted that in typical SABR treatment for patients, more beams are used 
during treatment to ensure conformal treatment while simultaneously sparing critical structures, 
including skin surfaces. 
 
First, the DVH for the MIP dataset was obtained. The moving target volume was identified using the 
auto-contouring option on the treatment planning system. On the MIP dataset, the delineated volume 




MLC aperture conformed to the target volume, with a 5mm margin added. 200MU of radiation was 
delivered to the target volume at both 6MV and 10MV beam energy on the Pinnacle
3 
treatment 
planning system. Then, Pinnacle
3
 determines the dose distribution to the delineated volume in the 
form of the cumulative and differential DVH graphs. The DVH graph for all the plans with the target 
moving in a combination of different magnitude and period was generated. The DVH graph was then 
exported onto Microsoft Excel, so that comparisons with other DVH graphs could be made. The 
MIP plan sufficiently represents the target volume and the corresponding range of motion. It is due 
to this that the MIP plan was copied onto other datasets, to provide the PTV volume. This is why the 
MIP plans are copied onto the AIP and FB datasets, to ensure that the same volume can be 
delineated on the MIP, AIP and FB datasets for dose distribution comparison. 
 
The MIP plan was then copied onto the AIP dataset using the dynamic planning tool available on 
Pinnacle
3
. On all the remaining plans, 200 MU of radiation was delivered to the moving target 
volume at 6MV and 10MV beam energy. On the AIP dataset, the delineated volume was defined by 
the MIP image, and the DVH graph was generated and exported onto Microsoft Excel so that 
comparisons with other DVH graphs could be made. Similarly, the same process was applied to the 
free breathing (23% phase) dataset. 
 
On each phase of the 4DCT dataset, the target volume was also delineated using the auto contour 
option on the treatment planning system. This volume makes up the GTV volume only on each 
phase of the 4DCT dataset, where only the target volume was contoured on each of the 8 phases. 
Again, 200MU of radiation was delivered to the target volume with beam energy of 6MV and 10MV 
on Pinnacle 
3
. The resultant DVH graphs for 8 phases of the 4DCT dataset as seen in Figure 5.2 was 
then exported onto Microsoft Excel. The DVH graphs for all 8 phases were added together, and 
averaged, to form the Average_GTV DVH graph as seen in Figure 5.3. The dose distribution at each 
phase was calculated, summed, and averaged across the 8 phases, to form the resultant 
Average_GTV DVH graphs. 
 
Table 5.1 This table summarizes briefly the different volumes delineated on the different images. 




MIP On the MIP dataset, the target volume with a 5mm margin was contoured. 
The delineated volume contains the target volume, as well as the entire range 
of motion of the target volume.  On the MIP dataset, each voxel represents 
the maximum voxel value derived from the 8 phases of the 4DCT dataset. 
The MIP DVH represents the dose distribution to this volume. 
AIP For target delineation, the MIP image was copied onto AIP image using the 
dynamic planning tool. On the AIP dataset, each voxel represents the 
average voxel value derived from the 8 phases of the 4DCT dataset. The AIP 
DVH represents the dose distribution calculated based on the AIP image 
with the PTV volume defined by the MIP image. 
Free 
Breathing 
For target delineation, the MIP image was copied onto free breathing 
image(23% phase dataset) using the dynamic planning tool. The 23% phase 
is chosen as it represents the approximate midpoint of the two extremes of 
the target motion. The Free Breathing DVH represents the dose distribution 
calculated based on the free breathing image, with the PTV volume defined 
by the MIP image. 
Average_GTV Only the 3cm diameter target, which makes up the GTV volume, was 
contoured in each of the 8 phases. The dose to the volume at each phase was 
obtained. All 8 DVH graphs were then summed and averaged, to produce the 
Avereage_GTV DVH graph. This Average_GTV graph represents the 
calculated dose at each phase to the GTV volume, that was then summed and 










Figure 5.2 The differential DVH for the GTV volume at the different phases of the 4DCT dataset at 10%, 22%, 35%, 47%, 60%, 72%, 
85%, and 97% phase. The GTV volume accounts for the target volume alone. These DVH graphs are reconstructed based on data 
exported from the Pinnacle Treatment planning system. The information was combined, to form the Average_GTV DVH graph. 
 
Figure 5.3 The Resultant DVH curve formed from averaging the DVH graphs from the 8 phases from the 4DCT dataset, to form the 
Average_GTV differential DVH curve. 
 
The tumour volume obtained using 4DCT scan is also known as the ITV region, that is the Internal 
Target Volume. This volume accounts for the target volume as well as an internal margin, which 
accounts for the variation in shape and size of the tumour as it moves. In SABR treatment, the ITV 
volume is essential in treatment planning for evaluation of the treatment plan. Generating the 
Average_GTV DVH is similar to obtaining the DVH for the ITV region for the 4DCT dataset. A 
quick summary of the different volumes delineated for comparisons are shown in Table 5.1. 
 
Then, the DVH graphs for the MIP, AIP, free breathing, and Average_GTV were put onto one single 




and AIP dataset, in comparison to the dose distribution on the 4DCT dataset. Comparisons are made 
to observe how well the dose distribution based on the MIP, AIP and free breathing dataset match 
the dose distribution on the 4DCT dataset. The purpose of the comparison is also to observe if the 
dose distribution based on the MIP or AIP image, are still comparable, as the magnitude of motion is 
increased. In this study, motion was only increased from 10mm, to 40mm in the Superior/Inferior 
(SI) direction. Anterior posterior (AP) motion was also added for some of the generated images. 
 
All DVH graphs were generated on the Treatment planning system. Once generated, the information 
was exported onto Microsoft Excel or Python so that they can be combined to form a new graph for 
comparison. This was necessary as the DVH graphs from the 8 phases of the 4DCT dataset was 
added together and averaged to form a new DVH graph. Comparisons were made between the DVH 
graphs for MIP, AIP, Free breathing image, Average_GTV and Average_PTV. The final graphs are 
normalized such that the comparisons were easier to see. Comparisons were made for the target 
volume moving at varying amplitudes and varying magnitudes of motion. 
 
Based on the data provided by the DVH graphs from the 4DCT images and the reconstructed 
images, the minimum, maximum and average dose calculated on all the images are also obtained. 







Figure 5.4 A brief flowchart showing the steps taken in generating the DVH graphs for comparison for the various datasets 
 
The flowchart in Figure 5.4 summarises the steps taken to generate the DVH graphs for the various 







The differential DVH is made up of equal sizes of dose(cGy) bins on the x-axis, and the y-axis 
represents the volume(cm
3
), receiving the corresponding amount of dose. The Cumulative DVH is 
also made up of equal sizes of dose(cGy) bins on the x-axis. However, on the cumulative DVH, the 
y axis represents the total volume(cm
3
), receiving greater than or equal to the corresponding dose. 
 
By comparing the DVH of the AIP, MIP and free breathing images on the same graph, the dose 
distribution planned on different image types can be seen more clearly. This gives us an indication of 
how well the dose distribution is based on the different image types, and how well they compare to 
one another. Keeping in mind that the main aim is to compare the equivalency of dose calculation on 
the reconstructed AIP, MIP datasets compared to dose calculation on each phase of the 4DCT 
dataset. Another aim is to observe if the equivalency holds, as the amplitude or magnitude of motion 
is increased. 
 
Comparing the MIP, AIP and Free breathing (23% phase) to the Average_GTV DVH graph 
 
Initially comparisons were just made between the MIP, AIP and Free breathing DVH graphs. During 
comparisons, the key points of the graphs can be analysed. That is, in the case of the differential 
DVH graph comparisons, to see how the peaks matched each other. In the case of the cumulative 
DVH graph comparisons, when the drop off on the graph begins, and how steep the fall off region is 
relative to each other. This also provides a basis of the dose distribution homogeneity and accuracy 







Figure 5.5 the differential DVH (a),(c) and cumulative DVH(b),(d)graphs produced, with period of 3 seconds with SI motion of 20mm 
for all the graphs at energy of 10MV or 10X. However (c), (d) AP motion of 10mm as well. The DVH shows the comparison of the 
DVH produced 
 
As seen in the Figure 5.5, as expected the DVH curve based on the MIP image showed the sharpest 
peak on the differential DVH, and the fall off begins the latest, with a significantly steep fall off 
slope, compared to the AIP and the free breathing image. From the results obtained, dose calculation 




delineated volume is greatest compared to the dose calculated based on the free breathing and AIP 
image. This is seen at both 6MV and 10MV. 
 
To observe the equivalency of using any of the reconstructed images (MIP, AIP, or free breathing) 
for dose calculations, comparisons are made with the Average_GTV DVH graph. Dose calculation 
based on each phase of the 4DCT image dataset best represent the dose distribution of the actual 
situation and how much dose is delivered to the target volume. 
 
 
Figure 5.6 The normalized differential and Cumulative comparison for the target volume moving with SI motion of 10mm, with a 





Figure 5.7 The normalized differential and Cumulative comparison for the target volume moving with SI motion of 20mm, with a 
period of 3 seconds with a beam energy of 6X. 
 
Figure 5.8 The normalized differential and Cumulative comparison for the target volume moving with SI motion of 40mm, with a 





Figure 5.9 The normalized differential and Cumulative comparison for the target volume moving with SI motion of 20mm, and AP 
motion of 10mm, with a period of 3 seconds with a beam energy of 6X 
 
As seen in the above figures (Figure 5.6,Figure 5.7,Figure 5.8,Figure 5.9) shows the DVH graphs of 
the target motion moving at varying amplitudes. The graphs shown have also been normalized by 
volume to compare the dose distribution. The graphs have been normalized according to the 
differential or cumulative volume respectively, such that the peaks and the fall off regions can be 
compared. While not all the DVH graphs are shown here, most of the obtained results show similar 
outcomes. As seen in the figures, the DVH graphs based on the MIP image shows the closest dose 
distribution equivalency to the Average_GTV graph, representing the dose distribution graph. This is 
the case even as the beam energy is increased from 6MV, to 10MV. As the amplitude of the SI 
motion is increased from 10mm to 40mm, the DVH curves show similar outcomes as well. 
 
The AIP dataset shows less agreement with the Average_GTV DVH curve. The DVH curve based 
on the AIP dataset show a lower dose distribution in comparison to the Average_GTV and MIP 
DVH. The DVH peak on the Differential DVH was observed to be more spread out with a wider 
calculated dose distribution in the lower range of dosages. The cumulative DVH for the AIP image 





The DVH curve based on the FB image showed even greater difference in comparison to the 
Average _GTV cumulative and differential DVH curves. The peaks are more spread out, showing 
that dose calculation based on the free breathing image has a lower range of dose distribution 
delivered to the target volume. In most of the comparisons made at the varying magnitudes of 
motion, the DVH curve calculated for the free breathing dataset showed the greatest difference with 
the Average_GTV curve. The DVH graph generated for both the AIP and free breathing dataset 
showed less equivalency and increasing the magnitude of motion resulted in the DVH curves to 
become only slightly less equivalent. 
 
In summary, based on the DVH curve, dose calculation based on the MIP dataset showed the closest 
dose distribution equivalency in comparison to the Average_GTV DVH curve. This holds true for up 
to 40mm, with superior inferior (SI) motion, even as the beam was increased from 6MV to 10MV. 
The AIP dataset and especially the free breathing dataset showed lesser equivalency when 
comparing the differential and cumulative DVH curves. 
 
According to the ICRU recommendations in ICRU report 50 [81] and ICRU report 62 [82], the 
recommended absorbed dose within the confined volume should be within -5% to +7% of the 
prescribed absorbed dose. Using this as a guide to see how well the reconstructed MIP, AIP and free 
breathing dataset compared to the 4DCT dataset, the % dose difference between the reconstructed 
images, and the 4DCT dataset is compared. The mean % dose difference in most cases shows 
relatively good agreement, where the % dose difference falls within the -5% to +7% range, despite 
the DVH curves not matching well in some cases. 
 
It is noted that there is a more recent and relevant report, the ICRU report 83 [83], which provides 
updated guidelines based on the ICRU reports 50 and 62, and ICRU report 91 [84] which provides 
fundamentals and a framework for stereotactic radiation therapy (SRT). Both report 83 and 91 
provides standardized procedures and techniques for prescribing recording and implementing IMRT 
and SRT, or in the context of this thesis, SABR treatment for patients, as a useful reference to 




results taken based on the CIRS Phantom provide a useful indication to what should be considered a 
clinically significant dose variation.  
 






 Pinnacle Calculated DVH dose 
6X 10X 
min max average min max average 
CIRS Motion p3 SI 10mm GTV 138.2 176.0 157.1 131.7 179.2 155.4 
3 second period with SI 
motion of 10mm 
MIP 144.7 176.0 160.4 138.2 181.4 159.8 
AIP 137.1 175.9 156.5 123.0 179.1 151.0 
22% 128.4 175.8 152.1 128.4 181.3 153.3 
                
CIRS Motion p3 SI 20mm GTV 137.4 178.9 158.2 131.3 184.5 157.9 
3 second period with SI 
motion of 20mm 
MIP 146.1 178.8 162.5 139.3 184.3 161.8 
AIP 136.3 177.7 157.0 121.0 182.1 151.5 
22% 126.5 178.8 152.6 127.2 180.6 153.9 
                
CIRS Motion P10s SI 10mm GTV 96.2 176.1 136.1 90.3 182.8 136.5 
10 second period with SI 
motion of 10mm 
MIP 145.9 176.1 161.0 139.4 181.6 160.5 
AIP 126.4 176.2 151.3 119.9 179.4 149.6 
22% 129.7 176.1 152.9 116.7 178.3 147.5 
                
CIRS Motion P10s SI 40mm GTV 134.1 181.4 157.7 125.9 188.3 157.1 
10 second period with SI 
motion of 40mm 
MIP 146.2 182.4 164.3 140.7 188.3 164.5 
AIP 130.9 177.1 154.0 122.1 178.2 150.2 
22% 129.6 180.1 154.9 120.8 185.6 153.2 
                
BCRPM 002 GTV 131.5 176.5 154.0 133.8 184.5 159.2 
5 second period with SI 
motion of 40mm 
6X 132.8 176.7 154.8 138.6 184.8 161.7 
6X 129.1 172.9 151.0 121.1 178.7 149.9 
  126.8 176.4 151.6 119.9 183.3 151.6 
                
BCRPM 003 GTV 128.2 173.6 150.9 129.3 179.2 154.3 
3 second period with SI 
motion of 10mm and AP 
motion of 10mm 
MIP 129.4 173.7 151.6 134.0 179.4 156.7 
AIP 128.2 171.3 149.8 123.7 175.9 149.8 
22% 125.9 170.2 148.0 121.4 177.0 149.2 
                
BCRPM 004 GTV 130.4 176.2 153.3 131.6 181.9 156.8 
3 second period with SI 
motion of 20mm and AP 
motion of 10mm 
MIP 131.7 176.4 154.1 136.3 183.3 159.8 
AIP 129.3 172.8 151.0 124.7 178.5 151.6 




                
BCRPM 005 GTV 130.0 178.3 154.1 127.7 185.2 156.4 
3 second period with SI 
motion of 30mm and AP 
motion of 10mm 
MIP 134.8 177.4 156.1 139.4 184.3 161.9 
AIP 132.2 174.7 153.4 125.3 179.3 152.3 
22% 126.6 173.8 150.2 123.1 180.7 151.9 
                
BCRPM 006 GTV 121.4 173.7 147.6 114.5 179.1 146.8 
5 second period with SI 
motion of 10mm and AP 
motion of 10mm 
MIP 128.4 173.8 151.1 131.8 179.5 155.6 
AIP 128.1 171.1 149.6 122.4 175.2 148.8 
22% 125.9 171.3 148.6 120.2 175.8 148.0 
                
BCRPM 011 GTV 105.2 175.0 140.1 100.5 182.7 141.6 
10 second period with SI 
motion of 20mm and AP 
motion of 10mm 
MIP 131.9 176.7 154.3 135.4 183.5 159.5 
AIP 129.3 172.8 151.0 127.0 178.5 152.8 
22% 69.2 169.0 119.1 61.2 172.4 116.8 
 
 
Table 5.3 The % dose difference between the reconstructed 4DCT dataset of MIP, AIP and free breathing, against the Average_GTV  






% dose difference with Average_GTV 
6X 10X 
min max average min max average 
CIRS Motion p3 SI 10mm GTV 0.0 0.0 0.0 0.0 0.0 0.0 
3 second period with SI motion 
of 10mm 
MIP -4.7 0.0 -2.1 -5.0 -1.2 -2.8 
AIP 0.8 0.0 0.4 6.6 0.1 2.8 
22% 7.1 0.1 3.2 2.5 -1.2 1.4 
                
CIRS Motion p3 SI 20mm GTV 0.0 0.0 0.0 0.0 0.0 0.0 
3 second period with SI motion 
of 20mm 
MIP -6.3 0.0 -2.7 -6.0 0.1 -2.4 
AIP 0.9 0.7 0.8 7.9 1.3 4.0 
22% 8.0 0.1 3.5 3.2 2.1 2.6 
                
CIRS Motion P10s SI 10mm GTV 0.0 0.0 0.0 0.0 0.0 0.0 
10 second period with SI motion 
of 10mm 
MIP -51.7 0.0 -15.8 -54.4 0.7 -17.5 
AIP -31.5 0.0 -9.7 -32.8 1.9 -9.6 
22% -34.8 0.0 -10.7 -29.2 2.4 -8.0 
                
CIRS Motion P10s SI 40mm GTV 0.0 0.0 0.0 0.0 0.0 0.0 
10 second period with SI motion 
of 40mm 
MIP -9.0 -0.6 -4.2 -11.7 0.0 -4.7 
AIP 2.4 2.3 2.4 3.0 5.3 4.4 




                
BCRPM 002 GTV 0.0 0.0 0.0 0.0 0.0 0.0 
5 second period with SI motion 
of 40mm 
6X -1.0 -0.2 -0.5 -3.6 -0.2 -1.6 
6X 1.8 2.0 1.9 9.5 3.2 5.8 
  3.6 0.0 1.5 10.4 0.7 4.8 
                
BCRPM 003 GTV 0.0 0.0 0.0 0.0 0.0 0.0 
3 second period with SI motion 
of 10mm and AP motion of 
10mm 
MIP -1.0 -0.1 -0.5 -3.6 -0.1 -1.6 
AIP 0.0 1.3 0.7 4.4 1.9 2.9 
22% 1.8 2.0 1.9 6.1 1.3 3.3 
                
BCRPM 004 GTV 0.0 0.0 0.0 0.0 0.0 0.0 
3 second period with SI motion 
of 20mm and AP motion of 
10mm 
MIP -1.0 -0.1 -0.5 -3.6 -0.7 -1.9 
AIP 0.9 1.9 1.5 5.2 1.9 3.3 
22% 1.8 2.0 1.9 7.9 1.9 4.4 
                
BCRPM 005 GTV 0.0 0.0 0.0 0.0 0.0 0.0 
3 second period with SI motion 
of 30mm and AP motion of 
10mm 
MIP -3.7 0.5 -1.3 -9.2 0.4 -3.5 
AIP -1.7 2.0 0.4 1.9 3.2 2.6 
22% 2.6 2.5 2.6 3.6 2.4 2.9 
                
BCRPM 006 GTV 0.0 0.0 0.0 0.0 0.0 0.0 
5 second period with SI motion 
of 10mm and AP motion of 
10mm 
MIP -5.7 -0.1 -2.4 -15.1 -0.2 -6.0 
AIP -5.4 1.5 -1.4 -6.9 2.2 -1.3 
22% -3.7 1.4 -0.7 -5.0 1.9 -0.8 
                
BCRPM 011 GTV 0.0 0.0 0.0 0.0 0.0 0.0 
10 second period with SI motion 
of 20mm and AP motion of 
10mm 
MIP -25.4 -1.0 -10.1 -34.7 -0.5 -12.6 
AIP -22.9 1.3 -7.8 -26.4 2.3 -7.9 
22% 34.2 3.4 15.0 39.0 5.6 17.5 
 
The table, Table 5.2, shows the minimum, maximum and average dose values obtained based on the 
DVH graphs produced on Pinnacle for the 4DCT dataset in comparison to the MIP, AIP, and free 
breathing(labelled as 22% in the table) dataset. In most cases as seen in the results above, Table 5.3, 
the % dose difference observed for the average dose falls within the -5% to +7% dose difference. 
The exception occurs only with the case of BCRPM011, and CIRS Motion P10 SI 10mm. In both 
cases, the target volume was moving at a period of 10 seconds, with the amplitude of motion in the 






Figure 5.10 This shows the Differential and cumulative DVH curve for a target volume moving with a period of 10 seconds, with 
amplitude of motion in the SI direction of 10mm. 
 
As seen in Figure 5.10,with the curve in red, representing the Average_GTV graph, on the 
differential DVH graph, there are small bumps in the curve, indicating that lower dose values are 
being delivered to very small volumes. This thus results in lower minimum dose, and thus a lower 






Figure 5.11 This shows the Differential and cumulative DVH curve for a target volume moving with a period of 10 seconds, with 
amplitude of motion in the SI direction of 20mm and 20mm in the AP direction. 
In the figure, Figure 5.11, the Average_GTV differential DVH shows that the minimum dose to the 
volume is lower than both the AIP and MIP minimum dose, while the maximum dose is also greater 
than MIP, AIP, and free breathing curves. Based on this result, the Average_GTV has a greater 
range of dose distribution to the moving target volume.  
 
In the two cases where the % dose difference between the Average_GTV volume, against the MIP, 
AIP, and Free breathing volume exceeded the -5% to  +7% dose difference, both had slow scanning 
protocols set in place, where the period of motion was 10 seconds, with SI motion being at 10mm( 
Figure 5.10) and 20mm (Figure 5.11) respectively. The discrepancy observed in the greater % dose 
difference could be due to the slow scan protocol implemented for the target volume moving with 
the 10 second period. Slow CT scan results in better ITV target delineation, however there could also 
be a loss of resolution and contrast because of motion blurring. This may have contributed to the 
discrepancy, and thus a greater difference in the calculated dose distribution seen. 
 
It is unlikely that the period of motion or the slow scanning protocol is the cause of the discrepancy. 




40mm, the % dose difference for the average dose all fell within the ICRU guideline. The 
Differential and cumulative DVH curve seen in Figure 5.12, show that the Average_GTV curve 
match the MIP and AIP curve well. The % dose difference for the Average dose to the moving target 
volume as seen in Table 5.3 for CIRS p10 SI 40mm, at 6MV and 10MV are within the acceptable 
range as well. 
 
 
Figure 5.12 This shows the Differential and cumulative DVH curve for a target volume moving with a period of 10 seconds, with 
amplitude of motion in the SI direction of 40mm. 
 
The results also show that increasing the beam energy to 10MV results in increased dose to the 
target volume. However, similar patterns are observed using 6MV and 10MV beams on the target 
volume. When comparing the % dose difference for the average dose between the Average_GTV 
DVH and the MIP, AIP and free breathing average dose, dose calculation on the reconstructed 
images are still comparable.  
 
However, results here for the DVH curves are obtained by dose calculation on Pinnacle for a small 
3cm in diameter moving target, moving at a maximum amplitude of 40mm in the SI direction, with a 




delivered dose to the target volume during respiration. Additionally, more beams will also be used 
for more conformal treatment to the target volume while simultaneously avoiding OARs. Additional 






Evaluation of the dose distribution to a moving target within heterogeneous condition can be 
complicated and requires careful evaluation. In the context of SABR treatment for NSCLC lung 
cancers, 4DCT imaging techniques are commonly used to track the moving tumour and how it 
changes throughout the respiration cycle within the lungs. The 4DCT images are commonly used 
and reconstructed to form MIP, AIP or free breathing images, as a quicker means to determine the 
dose distribution to the moving target volume. Treatment planning on the reconstructed dataset 
would be far less time consuming. This chapter focusses on determining the equivalency of 
treatment planning and dose calculation on the MIP, AIP or free breathing datasets, in comparison to 
treatment planning on the 4DCT dataset. This chapter also focuses on determining if the equivalency 
of dose calculation on the reconstructed dataset matches the 4DCT dataset as the magnitude of 
motion is increased. 
 
In this study, the dose calculation algorithm used was the same for all the images, which is the 
Pinnacle
3
 dose calculation algorithm, which accounts for the lung inhomogeneity correction. Dose 
calculation to a small field, moving within a low-density volume is a complex and complicated 
process. Different dose distribution due to electronic disequilibrium, due to varying densities and 
beam energies can occur. However, this study, dose calculation on all 4 datasets, the 4DCT, the MIP, 
AIP and free breathing dataset uses the same dose algorithm for dose comparison. Therefore, the 
comparison is mainly focused on whether dose calculation on the MIP, AIP or free breathing dataset, 





Only beam energies of 6MV and 10MV were used in this study. Higher energy beam allows the 
photons to travel deeper while simultaneously sparing healthy normal tissue. Additionally, dose 
uniformity in radial dose is also improved. However, at higher energies, a concern is that lateral 
electron disequilibrium can occur which can lead to under dosing. This effect is especially 
pronounced in low density mediums like the lungs, where the increased energy results in increased 
electron range, especially in low density mediums like the lungs, which can result in loss of dose to 
the central axis of the beam if the field size is not large enough. Lateral disequilibrium will show in 
the form of a broadened DVH graph at higher energy as seen in a study by Wang et al [85], that 
compared the DVH graphs obtained when using 6MV beam and 15 MV beam. Fortunately, based on 
the obtained results, at 10MV, lateral electronic disequilibrium is less significant. However at higher 
beam energies, like at 15MV [85], or 18MV [86], electronic disequilibrium can occur and the results 
can be affected greatly.  
 
In evaluating the dose distribution, observing the DVH graph gives a good visual way to determine 
the accuracy of dose calculation. The Average_GTV DVH curve represents most closely the amount 
of dose delivered to the target volume. As such it was used as a standard of comparison to for dose 
calculation based on the MIP, AIP and free breathing datasets. The main problem with DVH graph 
observation however, is the lack of spatial information. 
 
The Dose distribution seen for the Average_GTV DVH, results from taking the average dose 
distribution from all 8 phases and averaging the DVH formed by the 8 phases. While the volume 
delineated on each phase is smaller, the density representation at each phase for the GTV volume, 
was similar. Since dose calculation is based on the electron density, and the GTV volume contains 
only the target volume, the MIP image DVH is expected to have similar DVH curves to the Average 
GTV DVH. This was seen in the results as well.  
 
Equivalency between using MIP, AIP free breathing, vs 4DCT. 
 
The focus of this study was to evaluate the effect of treatment planning on reconstructed images, 
when the magnitude of motion for the small target is increased. The dose distribution was evaluated 




These represent motion due to the diaphragm and the chest wall respectively. For dose calculation, 
the physical size of the PTV volume used for dose calculation is the same.  
 
The MIP image suitably represented the extent of motion of the moving target volume, which is why 
the MIP image is copied on to the AIP and Free breathing datasets for target delineation. According 
to Bradley et al. [27], and Muirhead et al. [62], MIP images provide reliable enough representation 
of the volumes for target delineation, for early stage 1 NSCLC lung tumours. While the physical 
delineated target volume size is the same on MIP, AIP and free breathing datasets, under the same 
condition, the main difference of the three different reconstructed dataset, is the voxel/density 
representation. Based on the shape of the DVH graph alone, the dose distribution calculated based 
on the MIP image is closest to the Average_GTV curve. Dose calculation based on the AIP image 
showed lesser agreement, while dose calculation on the free breathing image shows the least 
agreement. 
 
In contrast, since calculating the dose on the AIP and free breathing image, there are also lung 
densities within the delineated volume, the calculated dose is thus lower as well. Since each pixel on 
the AIP dataset represents the average density across the 4DCT dataset, this resulted in a lower 
calculated dose. However, the AIP dataset showed more accurately the mean position of the target 
volume. Some studies have shown that while target delineation based on the MIP image for early 
stage tumour is relatively accurate, dose calculation based on the MIP image may be less accurate 
compared to dose calculations on other image types [30, 62]. Another study by Khamfongkhruea et 
al. [42] demonstrated that the AIP image and free breathing image could both be used for target 
delineation and dose calculation however caution should be taken with target delineation using free 
breathing images. Studies that have shown AIP images are suitable for dose calculation purposes 
[42, 71, 87]. However in the study by Khamfogkruea et al. [42], they have also shown that using a 
Mid-ventilation image is also suitable for dose calculation. This is the position of the tumour, at the 
mean tumour position. The phase at which this occurs is used for dose calculation. The 23% phase 
free breathing image is the closest to this location. It is possible that due to the increased magnitude 
of motion, as well as velocity, artifacts occur, affecting the image quality. This can be caused by 




reconstructed AIP image as well, leading to inaccurate dose calculations based on the delineated 
volume. 
 
The maximum, minimum, and average dose obtained for the DVH volume was also compared. The 
average dose to the delineated volume, based on the MIP, AIP and free breathing dataset, was in 
agreement to the 4DCT dataset. The percentage dose difference shows that there is a negative 
difference between the MIP dataset and the 4DCT dataset, while for the free breathing and AIP 
dataset, most of the % dose difference show a positive % dose difference. This indicates that dose 
calculation based on the MIP image, may result in slight underdosage to the moving target volume, 
while dose calculation based on the AIP and free breathing resulted in a positive % difference. The 
positive % dose difference implies that dose calculation based on the AIP and free breathing dataset 
result indicate that the maximum and average dose is greater, the minimum dose is also greater in 
value.  
 
In short, dose calculation based on the MIP image provided a narrower range of dose distribution, 
while dose calculation based on the AIP and free breathing dataset provided a wider range of dose 
distribution. However, the DVH graphs for this study show that dose calculation based on the MIP 
image provides better homogenous dose distribution relative to the DVH provided when planning on 
the 4DCT dataset. In contrast to this, the DVH based on the AIP and free breathing image, showed 
less homogeneity and accuracy. 
 
Equivalency as amplitude is added.  
 
The DVH curves shape showed that as amplitude is increased from 10mm, to 40mm, which is the 
greatest amplitude for target motion in this study, the AIP and free breathing DVH curves became 
less equivalent. Electronic disequilibrium is a factor to consider as well. Dose was calculated for a 
heterogeneous situation, where a single radiation beam was delivered to a 3cm moving target within 
the low-density lung equivalent phantom. As the beam travels through the different medium to the 
target volume, the small target volume size may not provide a sufficient volume for the buildup 






As the amplitude of motion was increased, the size of the volume increases, and there is more 
variation in the delineated volume, where more lung volume including the target volume is 
delineated. On the reconstructed image of the AIP and Free breathing images, as motion amplitude 
increased, the discrepancy between dose calculation on the AIP and free breathing image, in 
comparison to the 4DCT dataset increased. 
 
Despite lacking in the homogeneity in the DVH curves comparison, the results obtained show that 
the dose calculation on the AIP and free breathing images are still comparable, following the ICRU 
guidelines. It is likely that increasing the manitude of motion beyond 50mm, will result in much 
greater discrepancy where treatment planning based on the different reconstructed images becomes 
unsuitable. However, target motion exceeding 50mm is rare. However this is also dependent on the 
target volume location and size. Tumour volumes that are closer to the diaphragm experience greater 
motion due to respiration [48, 88]. Smaller tumour volumes are more mobile, whereas more 
advanced tumours are unlikely to exceed 10mm motion during normal breathing [48]. 
 
In a clinical situation, a patient’s lung is different from the phantom lung. Even though the phantom 
is meant to simulate a patient’s lung as closely as possible, the respiratory motion and lung and 
tumour geometry will not be as uniform as represented on the phantom. The purpose of this study 
was to evaluate if treatment planning and dose calculation on 4DCT represented images provided 
accurate or acceptable results. Based on the calculations done on Pinnacle, for motions of up to 
40mm, the DVH graphs show that the MIP image provides reliable comparison to treatment 
planning on 4DCT dataset. The AIP and free breathing dataset provides reliable comparisons as 
well, according to the ICRU guidelines, when comparing the maximum and minimum dose to the 
target volume. However, at larger amplitudes, the results may show something else. Based on the 
DVH graph trend, at higher amplitudes, the AIP and free breathing dataset may show more 
discrepancy and thus become unsuitable to be used for treatment planning. 
 
Typical radiotherapy methods incorporate multiple radiation beams to deliver a uniform dose 
distribution to the target volume while sparing the surrounding healthy tissue [88]. Incorporating 




discrepancies and errors. Additionally, in a clinical setting, patients that undergo SABR treatment for 
NSCLC lungs have irregular breathing patterns. The study here is based on the CIRS phantom, 
where target motion is periodically and consistently at the selected magnitude of motion. On the 
patient, the geometry and shape of the lung, as well as the magnitude of motion can be quite 
different and unpredictable on each patient. When target motion is irregular, even though 4DCT 
images provide important temporal and spatial information on the moving targets, the method is still 
limited by current technology [90]. Careful treatment planning on individual patients must be carried 
out to ensure that conformal treatment is administered to each patient without oversimplified 
assumptions. 
 
Therefore, in a clinical setting, it is prudent to not generalize that one specific reconstructed image 
type is suitable for treatment planning. Each patient will present with a different problem and with 
different target and lung geometries, for NSCLC patients. Careful treatment planning methods 
should be carried out to ensure accurate, homogenous treatment is delivered to the patient. This is 





The main aim of the study was to determine the equivalency of treatment planning on the MIP, AIP 
and free breathing dataset compared to treatment planning on the 4DCT dataset. Comparing the 
DVH curves, treatment planning based on the MIP showed the best equivalency in terms of 
homogeneity and accuracy. Upon comparing the % dose difference, dose calculation on the AIP and 
free breathing image, the mean dose to the delineated volume still fall within the ICRU 
recommendations.  
 
Another aim of the study was to determine if the reconstructed dataset of the MIP, AIP and free 
breathing dataset, was suitable for dose calculation as the amplitude of motion was increased. 
Comparing the DVH curve for the MIP dataset against the 4DCT dataset, good agreement can be 




breathing DVH graph shape became less equivalent to the 4DCT dataset, where the homogeneity 
became worse with increasing amplitude of motion. However, when comparing the % dose 
difference, the mean dose to the delineated volume still fall within the -5% and +7% dose range 
relative to the 4DCT dataset mean dose. However, the maximum amplitude of motion for the target 
was only at 40mm. At higher amplitudes, this may not be the case. 
 
The results were obtained based on dose calculation on Pinnacle, based on 4DCT images obtained 
from the CIRS lung phantom, with a perfectly spherical 3cm target volume moving at a constant rate 
within the phantom. In a clinical situation, treatment planning for a patient would involve patients 
with a range of different health levels where the geometry of the lung and target volume would vary. 
Additionally, the target volume may not move as periodically as seen on the phantom as well. 
Therefore, for the results to be clinically significant, studies involving real patients need to be carried 
out. SABR for stage I NSCLC cancer is a highly conformal method of treatment for lung cancers. 
Careful treatment planning is necessary to ensure that the target tumour volume is properly 
irradiated, and the OARs of the patient is protected. 
 
The results provide incremental confidence and guidance in applying MIP or AIP related 4DCT 






6. Summary and Conclusion. 
 
In this study, we evaluated the difference of treatment planning on different reconstructed images 
based on 4DCT images of a moving target within a low-density lung volume. This was done by 
imaging the CIRS lung phantom with a spherical moving target placed to simulate the motion of the 
tumour moving as a patient breathes. Motion of the tumour was mainly driven by diaphragm motion, 
with greatest motion typically in the superior-inferior direction. In this study, 4DCT images were 
taken of the CIRS phantom moving in the superior-inferior direction only, and when there was both 
superior-inferior and anterior-posterior motion. Superior inferior motion was increased in 10mm 
increments, from 10mm, 20mm, 30mm and finally 40mm. Images were taken at increasing 
magnitudes of motion to study the accuracy of the image representation, and the accuracy of 
treatment planning and dose calculation on the different reconstructed images.  
 
The purpose of treatment planning and dose calculation being done on these reconstructed images 
was to reduce the time involved in the treatment planning process. A 4DCT image set contains many 
images in many phases of breathing. Treatment planning based on all phases of breathing would be 
tedious and time consuming. Thus, a few different methods of image reconstruction were applied to 
the images to evaluate the accuracy of planning treatment for a moving target. In carrying out the 
study, 3 main research questions are answered.  
 
 
1) What impact does scan analysis techniques on 4DCT datasets (ie : MIP, AIP, specific 4DCT 
phase) have on CT number?  
The varying scan techniques resulted in different 4DCT datasets, with varying CT numbers. CT 
numbers were converted to physical density, which was obtained through an established relationship 
on Pinnacle
3
, the treatment planning system. The number was then converted to electron density for 
dose calculation. Despite varying CT numbers, the physical density of the delineated target volume 
on the MIP image and the free breathing image showed consistent and accurate physical density 




showed both lower CT number and physical density representation of the same delineated volume 
compared to the MIP and free breathing image. Therefore, despite varying CT numbers, the density 
values were comparable for the MIP and free breathing image. This is important as dose calculation 
is density dependent. 
 
2) What impact do different CT numbers derived from reconstructed 4DCT datasets have on dose 
calculated to a point? 
 
Based on the MIP, AIP and free breathing image, all with varying CT numbers, the dose to a point 
was calculated on the different reconstructed 4DCT dataset. The dose calculation algorithm was the 
same on all image datasets, using the Pinnacle
3
 calculation algorithm to determine the point dose. It 
was found that based on point dose measurements, dose calculation on the AIP image was the most 
accurate, whereas dose calculation on the MIP image and free breathing image was more accurate at 
10MV. The measured point dose to the phantom was found to be consistently greater than the 
calculated Pinnacle
3
 point dose, regardless of the image type. The discrepancy between the measured 
and calculated dose became more significant at 10MV. However, in radiotherapy, a more relevant 
and accurate assessment of the treatment plan would be to evaluate the dose to the entire volume, 
and not just the point dose measurements. Thus, the dose distribution to the delineated volume is 
evaluated as well.  
 
3) What impact does the different CT numbers derived from reconstructed 4DCT datasets have on 
dose calculated to a moving target volume?  
 
The dose distribution to the delineated volume was evaluated on the MIP, AIP and free breathing 
datasets by observing the DVH. It was found that the MIP image which represents the highest CT 
number and density on the image was most suitable for comparison for the dose to the delineated 
volume. This is true at both 6MV and 10MV beam energy, even as the magnitude of motion was 
increased. As the magnitude of motion was increased, the accuracy of the dose distribution 
deteriorated on the AIP and free breathing image, in comparison to dose calculation on the 4DCT 
dataset. However, in comparing the % dose difference, the mean dose difference in most cases for 




motion beyond 50mm, this may not be the case, and using AIP or free breathing dataset for dose 
calculation may be less suitable. Dose calculation to a moving target is complicated and can be 
affected by multiple factors. It is difficult to generalize that a specific image is more suitable than 
another.  
 
 The results here are obtained for a lung equivalent phantom, with a small spherical target moving 
within the lungs. This is to simulate a stage 1 non-small cell lung cancer (NSCLC) scenario within 
the patient. The simulation is for a target moving with a maximum SI motion of 40mm, within the 
low-density lungs that is 3cm in diameter, and is not attached to the diaphragm, or bronchi of the 
lungs. The difference and potential over simplification of this study is that clinical patients will 
present with tumour shapes of varying shapes and size, with irregular breathing patterns, compared 
to the observed results in this study. Evaluation of the dose distribution to real patients will give a 
better indication of the accuracy of the results found in this study. However, this study provides a 
basis of assessing patients with stage 1 NSCLC through simulations on the CIRS phantom, and dose 
calculations carried out on the Pinnacle treatment planning system. 
 
The results obtained for the simplified phantom geometry and motions may help provide incremental 
confidence and guidance in applying varying scanning techniques like MIP or AIP related 4DCT 
procedures, especially in dynamically moving treatment planning and radiation dose delivery for 
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A.1 Calibration for Ion Chamber for measurements of dose to a point 
in Chapter 4. 
 
The ionization chamber here was calibrated for measurement of the dose to a point in the target 
volume moving within the CIRS lung phantom. Measurements were recorded and compared to 
calculated point dose values from Pinnacle, with simulated target motion at the same magnitude of 
motion. The setup is seen in Figure A.1.  
 
From literature, dmax usually occurs at 1.5cm, and 2.1cm for 6MV and 10MV respectively. Using 
this method, the charge reading obtained can be converted into dose reading. From our study, dmax at 
6X occurs at 1.5cm depth, while for 10X, it occurs at approximately 2.4 cm depth. 
 
 




Ionization chamber readings are measured in terms of charge (nC). To convert it to dose (cGy), we 
take the measured reading as a ratio of the charge at dmax, multiplied with any necessary correction 
factor, to obtain the dose values. 
𝑑𝑜𝑠𝑒(𝑐𝐺𝑦) =    
𝑐ℎ𝑎𝑟𝑔𝑒(𝑛𝐶)
𝑐ℎ𝑎𝑟𝑔𝑒 𝑎𝑡 𝑑𝑚𝑎𝑥(𝑛𝐶)
 x 100 (𝑐𝐺𝑦) x 𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟. 
 
The correction factor is necessary because measurements were taken at separate times. 2 different 
types of correction factors are applied to the measured data. During the setup for each day, the start 
and end reading did not vary significantly. However, when comparing the start and end 
measurements for different days, difference is relatively significant. To account for this, a correction 
factor(k1) is applied to the second set of data. This is done by taking the sum of the measurements at 
the start, and end of the first setup, divided by the sum of the measurements at the start and end of 
the second setup: 










Another correction used is the correction used for temperature and pressure differences. For the first 
setup, the temperature and pressure is at 22.4°C (295.55 K) and 99.95kPa respectively. With the 
second setup, the temperature and pressure is at 23.1°C(296.25K) and 100.62kPa the respectively. 
Using ideal gas law to relate these two variables, we get the relationship that PV = nRT, where P is 
pressure, V is the volume, n is the number of moles, R is the gas constant, and T is the temperature.  
𝑃1𝑉 = 𝑛𝑅𝑇1 
𝑃2𝑉 = 𝑛𝑅𝑇2 
The volume does not change, and number of moles as well as the gas constant, R, are constants in 
this case. To relate the data from first setup to second setup, a correction factor 𝑘𝑇,𝑃 can be applied 
such that 
𝑘𝑇,𝑃𝑃1𝑉 = 𝑃2𝑉 








The value of  𝑘𝑇,𝑃 , thus works out to be 1.0043. This correction factor is only applied to the data 
obtained from the first setup.  
Now converting the obtained charge values to dose involves taking it as a ratio to the charge at 
dmax, multiplied by the correction factors where necessary. 
𝑑𝑜𝑠𝑒(𝑐𝐺𝑦) =    
𝑐ℎ𝑎𝑟𝑔𝑒(𝑛𝐶)
𝑐ℎ𝑎𝑟𝑔𝑒 𝑎𝑡 𝑑𝑚𝑎𝑥(𝑛𝐶)
 x 100 (𝑐𝐺𝑦) x 𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟. 
 For example: 
At 6X, for the first setup for CIRS Motion P3s SI 10mm, the measured charge is -1.83 nC. The 
measurement at dmax for 6X obtained from the water tank measurement is -1.043nC. Applying the 
𝑘𝑇,𝑃 correction as well gives a value of 176.21cGy. 
 
A.2 Point Dose comparisons for Chapter 4 
 
The calculated dose to a point values as determined on Pinnacle treatment planning system for the 
MIP, AIP, Free Breathing, in comparison with the measured static and measured moving point dose 
values. This A.2 sub chapter will show the point dose value comparisons for 3 seconds, 5 seconds, 






Figure A.2 Point dose comparison at 6MV with only SI motion at 10mm, 20mm, and 30mm, at period of 3 seconds, based on various 
reconstructed images. 
Table A.1 Point dose (cGy) comparison with only SI motion  for 10mm, 20mm and 30mm for the various reconstructed images with a 
period of 3 seconds 
CIRS MOTION P3 
  10mm(cGy) 20mm(cGy) 30mm(cGy) 
MIP(3 secs) 171.20 172.7 172.9 
AIP(3 secs) 172.00 174.0 173.7 
Free Breathing(3 secs) 171.90 173.5 173.7 
static(3 secs) 176.21 177.66 177.75 































Figure A.3 Point dose comparison at 6MV with only SI motion at 10mm, 20mm, 30mm, and 40mm at period of 5 seconds, based on 
various images. 
Table A.2 Point dose (cGy) comparison with only SI motion for 10mm, 20mm, 30mm and 40mm for the various reconstructed images 
with a period of 5 seconds 
CIRS Motion P5 
  10mm(cGy) 20mm(cGy) 30mm(cGy) 40mm(cGy) 
MIP(5 secs) 171.2 173.0 167.8 174.1 
AIP(5 secs) 171.2 173.8 169.8 173.4 
Free Breathing(5 secs) 170.2 172.8 170.3 175.0 
static(5 secs) 176.07 177.71 178.91 179.73 

































Figure A.4 Point dose comparison at 6MV with only SI motion at 10mm, 20mm, 30mm, and 40mm at period of 10 seconds, based on 
various reconstructed images. 
Table A.3 Point dose (cGy) comparison with only SI motion for 10mm, 20mm, 30mm and 40mm for the various reconstructed images 
with a period of 10 seconds 
CIRS Motion P10 
  10mm(cGy) 20mm(cGy) 30mm(cGy) 40mm(cGy) 
MIP(10 secs) 171.6 173.4 168.2 175.8 
AIP(10 secs) 172.2 174.4 170.6 176.1 
Free Breathing(10 secs) 171.7 173.7 168.1 176.8 
static(10 secs) 176.31 177.66 177.09 179.63 

































Figure A.5 Point dose comparison at 6MV with SI motion and AP motion at 10mm, 20mm and 30mm at period of 3 seconds, based on 
various reconstructed images. 
Table A.4 Point dose (cGy) comparison with SI motion and AP motion for 10mm, 20mm and 30mm for the various reconstructed 
images with a period of 3 seconds 
BCRPM 003,004,005 
 amplitude 10mm(cGy) 20mm(cGy) 30mm(cGy) 
MIP 163.4 166.1 167.6 
AIP 166.5 168.5 170.2 
Free Breathing 166.7 168.6 169.3 
static 173.85 175.72 176.94 



























Figure A.6 Point dose comparison at 6MV with SI motion and AP motion at 10mm, 20mm, 30mm, and 40mm at period of 5 seconds, 
based on various reconstructed images. 
Table A.5 Point dose (cGy) comparison with SI motion and AP motion for 10mm, 20mm, 30mm and 40mm for the various 
reconstructed images with a period of 5 seconds 
BCRPM 006,007,008,009 
 amplitude 10mm(cGy) 20mm(cGy) 30mm(cGy) 40mm(cGy) 
MIP 163.2 165.6 168.2 169.7 
AIP 166.7 168.7 170.2 171.1 
Free Breathing 166.6 168.0 169.4 170.7 
static 173.76 175.47 176.89 178.07 

































Figure A.7 Point dose comparison at 6MV with SI motion and AP motion at 10mm, 20mm, 30mm, and 40mm at period of 5 seconds, 
based on various reconstructed images. 
Table A.6 Point dose (cGy) comparison with SI motion and AP motion for 10mm, 20mm, 30mm and 40mm for the various 
reconstructed images with a period of 10 seconds 
BCRPM 010,011,012,013 
 amplitude 10mm(cGy) 20mm(cGy) 30mm(cGy) 40mm(cGy) 
MIP 163.1 166.1 168.2 169.5 
AIP 166.5 168.8 170.2 171.0 
Free Breathing 166.2 165.4 168.4 170.2 
static 173.71 175.47 176.79 177.92 
moving 173.85 175.81 177.28 178.41 
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Figure A.8 Point dose comparison at 10 MV with only SI motion at 10mm, 20mm and 30mm at period of 3 seconds, based on various 
reconstructed images. 
Table A.7 Point dose (cGy) comparison with only SI motion  for 10mm, 20mm and 30mm for the various reconstructed images with a 





























CIRS MOTION P3 
 amplitude 10mm(cGy) 20mm(cGy) 30mm(cGy) 
MIP(3 secs) 179.90 182.4 182.9 
AIP(3 secs) 178.60 180.4 178.4 
Free Breathing(3 secs) 178.70 181.1 181.3 
static(3 secs) 184.71 186.80 187.09 





Figure A.9 Point dose comparison at 10 MV with only SI motion at 10mm, 20mm, 30mm, and 40mm at period of 5 seconds, based on 
various reconstructed images. 
Table A.8 Point dose (cGy) comparison with only SI motion for 10mm, 20mm, 30mm and 40mm for the various reconstructed images 
with a period of 5 seconds at 10MV 
CIRS MOTION P5 
amplitude 10mm(cGy) 20mm(cGy) 30mm(cGy) 40mm(cGy) 
MIP(5 secs) 180.0 182.5 179.6 182.2 
AIP(5 secs) 173.1 176.8 175.0 177.8 
Free Breathing(5 secs) 170.3 177.5 177.3 179.9 
static(5 secs) 184.71 186.85 188.51 189.70 





























Figure A.10 Point dose comparison at 10 MV with only SI motion at 10mm, 20mm, 30mm, and 40mm at period of 10 seconds, based 
on various reconstructed images. 
Table A.9  Point dose (cGy) comparison with only SI motion for 10mm, 20mm, 30mm and 40mm for the various reconstructed images 
with a period of 10 seconds at 10MV 
 
CIRS MOTION P10 
amplitude 10mm(cGy) 20mm(cGy) 30mm(cGy) 40mm(cGy) 
MIP(10 secs) 180.3 182.9 180.3 185.6 
AIP(10 secs) 176.6 181.4 177.2 177.9 
Free Breathing(10 secs) 175.5 181.4 179.5 183.5 
static(10 secs) 184.90 187.09 187.96 189.37 


















10MV Dose comparison with SI motion at 10 seconds 
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Figure A.11 Point dose comparison at 10MV with SI motion and AP motion at 10mm, 20mm and 30mm at period of 3 seconds, based 
on various reconstructed images. 
Table A.10 Point dose (cGy) comparison with only SI motion and AP motion for 10mm, 20mm and 30mm for the various 
reconstructed images with a period of 3 seconds at 10MV 
BCRPM 003,004,005 
amplitude 10mm(cGy) 20mm(cGy) 30mm(cGy) 
MIP(3 secs) 175.4 178.2 179.9 
AIP(3 secs) 175.0 177.1 177.7 
Free Breathing(3 secs) 174.9 177.4 178.8 
static(3 secs) 183.63 185.99 187.62 



















Figure A.12 Point dose comparison at 10MV with SI motion and AP motion at 10mm, 20mm, 30mm, and 40mm at period of 5 seconds, 
based on various reconstructed images. 
Table A.11 Point dose (cGy) comparison with only SI motion and AP motion for 10mm, 20mm,30mm and 40mm for the various 
reconstructed images with a period of 5 seconds at 10MV 
BCRPM 006,007,008,009 
amplitude 10mm(cGy) 20mm(cGy) 30mm(cGy) 40mm(cGy) 
MIP(5 secs) 175.4 178.0 180.2 181.7 
AIP(5 secs) 174.5 176.5 177.0 177.0 
Free Breathing(5 secs) 174.7 177.6 179.5 180.7 
static(5 secs) 183.24 185.75 187.48 188.92 
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Figure A.13 Point dose comparison at 10MV with SI motion and AP motion at 10mm, 20mm, 30mm, and 40mm at period of 10 
seconds, based on various reconstructed images. 
Table A.12  Point dose (cGy) comparison with only SI motion and AP motion for 10mm, 20mm,30mm and 40mm for the various 
reconstructed images with a period of 10 seconds at 10MV 
 
BCRPM 010,011,012,013 
  10mm(cGy) 20mm(cGy) 30mm(cGy) 40mm(cGy) 
MIP(10 secs) 175.4 178.2 180.2 181.6 
AIP(10 secs) 174.5 176.3 177.0 176.9 
Free Breathing(10 secs) 175.3 172.0 180.0 180.9 
static(10 secs) 183.10 185.55 187.43 188.73 





























Differential Volume Histogram Graph Comparisons for Chapter 5. 
 
This subchapter will show the remaining DVH graphs not included in Chapter 5. The comparisons 
will show the DVH curve for MIP, AIP and Free breathing images. In the graphs shown below, the 
curve labelled 23% phase represents the DVH curve for the Free breathing image. The following 
DVH curves show the comparison of the DVH curves between the Average_GTV graph, in 
comparison to the reconstructed MIP, AIP and Free breathing images, at various amplitudes, and 
periods of motion with beam energies of 6MV and 10MV. 
 
 
Figure B.14 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with 





Figure B.15 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with 
target motion moving 10mm in the SI direction and 10mm in the AP direction, with a period of 3 seconds with 6MV beam energy. 
 
 
Figure B.16 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with 





Figure B.17  DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with 
target motion moving 30mm in the SI direction and 10mm in the AP direction, with a period of 3 seconds with 6MV beam energy. 
 
Figure B.18 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with 





Figure B.19 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with 
target motion moving 20mm in the SI direction and 10mm in the AP direction, with a period of 10 seconds with 6MV beam energy. 
 
Figure B.20  DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with 






Figure B.21 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with 
target motion moving 20mm in the SI direction with no AP motion, with a period of 3 seconds with 6MV beam energy. 
 
Figure B.22 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with 





Figure B.23 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with 
target motion moving 10mm in the SI direction with no AP motion, with a period of 10 seconds with 6MV beam energy. 
 
Figure B.24 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with 
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Figure B.25  DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with 






Figure B.26 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with 
target motion moving 10mm in the SI direction and 10mm in the AP direction, with a period of 3 seconds with 10MV beam energy. 
 
 
Figure B.27 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with 





Figure B.28 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with 
target motion moving 30mm in the SI direction and 10mm in the AP direction, with a period of 3 seconds with 10MV beam energy. 
 
 
Figure B.29 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with 





Figure B.30 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with 
target motion moving 20mm in the SI direction and 30mm in the AP direction, with a period of 10 seconds with 10MV beam energy. 
 
Figure B.31 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with 





Figure B.32 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with 
target motion moving 20mm in the SI direction and no AP motion, with a period of 3 seconds with 10MV beam energy. 
 
Figure B.33 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with 






Figure B.34 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with 
target motion moving 10mm in the SI direction and no AP motion, with a period of 10 seconds with 10MV beam energy. 
 
Figure B.35 DVH graph comparison for dose distribution between the 4DCT dataset, with MIP, AIP, and free breathing dataset, with 
target motion moving 40mm in the SI direction and no AP motion, with a period of 10 seconds with 10MV beam energy. 
 
